<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="shortcut icon" href="https://www.biorxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/biorxiv/early/2020/04/05/2020.04.01.019877.atom" />
<meta name="HW.pisa" content="biorxiv;2020.04.01.019877v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo" />
<meta name="DC.Identifier" content="10.1101/2020.04.01.019877" />
<meta name="DC.Date" content="2020-04-05" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory" />
<meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission." />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="SARS-CoV-2 has rapidly become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as a promising platform for vaccination. Here, we systematically investigated the untranslated regions (UTRs) of mRNAs in order to enhance protein production. Through a comprehensive analysis of endogenous gene expression and de novo design of UTRs, we identified the optimal combination of 5’ and 3’ UTR, termed as NASAR, which was five to ten-fold more efficient than the tested endogenous UTRs. More importantly, NASAR mRNAs delivered by lipid-derived nanoparticles showed dramatic expression of potential SARS-CoV-2 antigens both in vitro and in vivo. These NASAR mRNAs merit further development as alternative SARS-CoV-2 vaccines." />
<meta name="DC.Contributor" content="Chunxi Zeng" />
<meta name="DC.Contributor" content="Xucheng Hou" />
<meta name="DC.Contributor" content="Jingyue Yan" />
<meta name="DC.Contributor" content="Chengxiang Zhang" />
<meta name="DC.Contributor" content="Wenqing Li" />
<meta name="DC.Contributor" content="Weiyu Zhao" />
<meta name="DC.Contributor" content="Shi Du" />
<meta name="DC.Contributor" content="Yizhou Dong" />
<meta name="article:published_time" content="2020-04-05" />
<meta name="article:section" content="New Results" />
<meta name="citation_title" content="Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo" />
<meta name="citation_abstract" lang="en" content="&lt;p&gt;SARS-CoV-2 has rapidly become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as a promising platform for vaccination. Here, we systematically investigated the untranslated regions (UTRs) of mRNAs in order to enhance protein production. Through a comprehensive analysis of endogenous gene expression and de novo design of UTRs, we identified the optimal combination of 5′ and 3′ UTR, termed as NASAR, which was five to ten-fold more efficient than the tested endogenous UTRs. More importantly, NASAR mRNAs delivered by lipid-derived nanoparticles showed dramatic expression of potential SARS-CoV-2 antigens both in vitro and in vivo. These NASAR mRNAs merit further development as alternative SARS-CoV-2 vaccines.&lt;/p&gt;" />
<meta name="citation_journal_title" content="bioRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory" />
<meta name="citation_publication_date" content="2020/01/01" />
<meta name="citation_mjid" content="biorxiv;2020.04.01.019877v1" />
<meta name="citation_id" content="2020.04.01.019877v1" />
<meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1" />
<meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1.abstract" />
<meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1.full" />
<meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877.full.pdf" />
<meta name="citation_doi" content="10.1101/2020.04.01.019877" />
<meta name="citation_num_pages" content="16" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_section" content="New Results" />
<meta name="citation_firstpage" content="2020.04.01.019877" />
<meta name="citation_author" content="Chunxi Zeng" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Xucheng Hou" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Jingyue Yan" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Chengxiang Zhang" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Wenqing Li" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Weiyu Zhao" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Shi Du" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author" content="Yizhou Dong" />
<meta name="citation_author_institution" content="Division of Pharmaceutics &amp; Pharmacology, College of Pharmacy, The Ohio State University" />
<meta name="citation_author_institution" content="Department of Biomedical Engineering, Center for Clinical and Translational Science, Comprehensive Cancer Center, Dorothy M. Davis Heart &amp; Lung Research Institute, Department of Radiation Oncology, The Ohio State University" />
<meta name="citation_author_email" content="dong.525@osu.edu" />
<meta name="citation_reference" content="World Health Organization. Coronavirus disease (COVID-19) outbreak situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 March 29, 2020" />
<meta name="citation_reference" content="Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 395, 565–574 (2020)." />
<meta name="citation_reference" content="Centers for Disease Control and Prevention. Information for Clinicians on Therapeutic Options for COVID-19 Patients. https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html March 29, 2020" />
<meta name="citation_reference" content="Mascola, J.R. &amp; Fauci, A.S. Novel vaccine technologies for the 21st century. Nature Reviews Immunology 20, 87–88 (2020)." />
<meta name="citation_reference" content="World Health Organization. DRAFT landscape of COVID-19 candidate vaccines - 20 March 2020. https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1 March 29, 2020" />
<meta name="citation_reference" content="Maruggi, G., Zhang, C., Li, J., Ulmer, J.B. &amp; Yu, D. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. Molecular therapy : the journal of the American Society of Gene Therapy 27, 757–772 (2019)." />
<meta name="citation_reference" content="Pardi, N., Hogan, M.J., Porter, F.W. &amp; Weissman, D. mRNA vaccines - a new era in vaccinology. Nature reviews. Drug discovery 17, 261–279 (2018)." />
<meta name="citation_reference" content="Chatterjee, S. &amp; Pal, J.K. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biology of the Cell 101, 251–262 (2009)." />
<meta name="citation_reference" content="Jackson, N.A.C., Kester, K.E., Casimiro, D., Gurunathan, S. &amp; DeRosa, F. The promise of mRNA vaccines: a biotech and industrial perspective. npj Vaccines 5, 11 (2020)." />
<meta name="citation_reference" content="Hinnebusch, A.G., Ivanov, I.P. &amp; Sonenberg, N. Translational control by 5’-untranslated regions of eukaryotic mRNAs. Science (New York, N.Y.) 352, 1413–1416 (2016)." />
<meta name="citation_reference" content="Mayr, C. Regulation by 3′-Untranslated Regions. Annual Review of Genetics 51, 171–194 (2017)." />
<meta name="citation_reference" content="Ferizi, M. et al. Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts. Scientific reports 6, 39149 (2016)." />
<meta name="citation_reference" content="Babendure, J.R., Babendure, J.L., Ding, J.-H. &amp; Tsien, R.Y. Control of mammalian translation by mRNA structure near caps. RNA 12, 851–861 (2006)." />
<meta name="citation_reference" content="Trepotec, Z. et al. Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5’-UTRs. Tissue engineering. Part A 25, 69–79 (2019)." />
<meta name="citation_reference" content="Sample, P.J. et al. Human 5′ UTR design and variant effect prediction from a massively parallel translation assay. Nature Biotechnology 37, 803–809 (2019)." />
<meta name="citation_reference" content="Lee, J. et al. mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors. The Journal of clinical investigation 127, 2433–2437 (2017)." />
<meta name="citation_reference" content="Richner, J.M. et al. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell 168, 1114-1125.e1110 (2017)." />
<meta name="citation_reference" content="Schrom, E. et al. Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA. Molecular therapy. Nucleic acids 7, 350–365 (2017)." />
<meta name="citation_reference" content="Schwanhäusser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337–342 (2011)." />
<meta name="citation_reference" content="Yoshihama, M. et al. The human ribosomal protein genes: sequencing and comparative analysis of 73 genes. Genome research 12, 379–390 (2002)." />
<meta name="citation_reference" content="Yamashita, R. et al. Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristics. Nucleic Acids Res 36, 3707–3715 (2008)." />
<meta name="citation_reference" content="Geyer, P.E. et al. Plasma Proteome Profiling to Assess Human Health and Disease. Cell systems 2, 185–195 (2016)." />
<meta name="citation_reference" content="Bai, Y., Zhou, K. &amp; Doudna, J.A. Hepatitis C virus 3’UTR regulates viral translation through direct interactions with the host translation machinery. Nucleic Acids Res 41, 7861–7874 (2013)." />
<meta name="citation_reference" content="Huang, P.-S., Boyken, S.E. &amp; Baker, D. The coming of age of de novo protein design. Nature 537, 320–327 (2016)." />
<meta name="citation_reference" content="Kozak, M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. Journal of molecular biology 196, 947–950 (1987)." />
<meta name="citation_reference" content="Hinnebusch, A.G. Structural Insights into the Mechanism of Scanning and Start Codon Recognition in Eukaryotic Translation Initiation. Trends in biochemical sciences 42, 589–611 (2017)." />
<meta name="citation_reference" content="Chen, S.J. RNA folding: Conformational statistics, folding kinetics, and ion electrostatics. Annual Review of Biophysics 37, 197–214 (2008)." />
<meta name="citation_reference" content="He, L. &amp; Hannon, G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics 5, 522–531 (2004)." />
<meta name="citation_reference" content="Ricci, E.P. et al. miRNA repression of translation in vitro takes place during 43S ribosomal scanning. Nucleic Acids Res 41, 586–598 (2013)." />
<meta name="citation_reference" content="Hentze, M.W., Castello, A., Schwarzl, T. &amp; Preiss, T. A brave new world of RNA-binding proteins. Nature Reviews Molecular Cell Biology 19, 327–341 (2018)." />
<meta name="citation_reference" content="Yamagishi, R., Tsusaka, T., Mitsunaga, H., Maehata, T. &amp; Hoshino, S. The STAR protein QKI-7 recruits PAPD4 to regulate post-transcriptional polyadenylation of target mRNAs. Nucleic Acids Res 44, 2475–2490 (2016)." />
<meta name="citation_reference" content="Galarneau, A. &amp; Richard, S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nature Structural &amp; Molecular Biology 12, 691–698 (2005)." />
<meta name="citation_reference" content="Zearfoss, N.R., Clingman, C.C., Farley, B.M., McCoig, L.M. &amp; Ryder, S.P. Quaking Regulates Hnrnpa1 Expression through Its 3′ UTR in Oligodendrocyte Precursor Cells. PLOS Genetics 7, e1001269 (2011)." />
<meta name="citation_reference" content="Topisirovic, I. et al. Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer. Molecular and cellular biology 29, 1152–1162 (2009)." />
<meta name="citation_reference" content="Sokoloski, K.J. et al. Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells. Cell Host Microbe 8, 196–207 (2010)." />
<meta name="citation_reference" content="Terenin, I.M., Andreev, D.E., Dmitriev, S.E. &amp; Shatsky, I.N. A novel mechanism of eukaryotic translation initiation that is neither m7G-cap-, nor IRES-dependent. Nucleic Acids Res 41, 1807–1816 (2013)." />
<meta name="citation_reference" content="Fernandez, N. et al. Structural basis for the biological relevance of the invariant apical stem in IRES-mediated translation. Nucleic Acids Res 39, 8572–8585 (2011)." />
<meta name="citation_reference" content="Jiang, S., He, Y. &amp; Liu, S. SARS vaccine development. Emerging infectious diseases 11, 1016–1020 (2005)." />
<meta name="citation_reference" content="Leung, D.T. et al. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. The Journal of infectious diseases 190, 379–386 (2004)." />
<meta name="citation_reference" content="He, Y., Zhou, Y., Siddiqui, P., Niu, J. &amp; Jiang, S. Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus. Journal of Clinical Microbiology 43, 3718 (2005)." />
<meta name="citation_reference" content="Schoeman, D. &amp; Fielding, B.C. Coronavirus envelope protein: current knowledge. Virology Journal 16, 69 (2019)." />
<meta name="citation_reference" content="Li, B. et al. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. Nano Letters 15, 8099–8107 (2015)." />
<meta name="citation_reference" content="Zhang, L., Wang, W. &amp; Wang, S. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines 14, 1509–1523 (2015)." />
<meta name="citation_reference" content="Hassett, K.J. et al. Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines. Molecular Therapy - Nucleic Acids 15, 1–11 (2019)." />
<meta name="citation_reference" content="Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nature Nanotechnology 14, 1084–1087 (2019)." />
<meta name="citation_reference" content="Klauer, A.A. &amp; van Hoof, A. Degradation of mRNAs that lack a stop codon: a decade of nonstop progress. Wiley Interdiscip Rev RNA 3, 649–660 (2012)." />
<meta name="citation_reference" content="Mann, M., Wright, P.R. &amp; Backofen, R. IntaRNA 2.0: enhanced and customizable prediction of RNA–RNA interactions. Nucleic Acids Res 45, W435–W439 (2017)." />
<meta name="citation_reference" content="Chen, Y. &amp; Wang, X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48, D127–D131 (2019)." />
<meta name="citation_reference" content="Li, B., Zeng, C. &amp; Dong, Y. Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing. Nat Protoc 13, 899–914 (2018)." />
<meta name="twitter:title" content="Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo" />
<meta name="twitter:site" content="@biorxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="twitter:description" content="SARS-CoV-2 has rapidly become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as a promising platform for vaccination. Here, we systematically investigated the untranslated regions (UTRs) of mRNAs in order to enhance protein production. Through a comprehensive analysis of endogenous gene expression and de novo design of UTRs, we identified the optimal combination of 5’ and 3’ UTR, termed as NASAR, which was five to ten-fold more efficient than the tested endogenous UTRs. More importantly, NASAR mRNAs delivered by lipid-derived nanoparticles showed dramatic expression of potential SARS-CoV-2 antigens both in vitro and in vivo. These NASAR mRNAs merit further development as alternative SARS-CoV-2 vaccines." />
<meta name="og-title" property="og:title" content="Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo" />
<meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1" />
<meta name="og-site-name" property="og:site_name" content="bioRxiv" />
<meta name="og-description" property="og:description" content="SARS-CoV-2 has rapidly become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as a promising platform for vaccination. Here, we systematically investigated the untranslated regions (UTRs) of mRNAs in order to enhance protein production. Through a comprehensive analysis of endogenous gene expression and de novo design of UTRs, we identified the optimal combination of 5’ and 3’ UTR, termed as NASAR, which was five to ten-fold more efficient than the tested endogenous UTRs. More importantly, NASAR mRNAs delivered by lipid-derived nanoparticles showed dramatic expression of potential SARS-CoV-2 antigens both in vitro and in vivo. These NASAR mRNAs merit further development as alternative SARS-CoV-2 vaccines." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="citation_date" content="2020-04-05" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/2020.04.01.019877v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/2020.04.01.019877v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/2020.04.01.019877v1.ppt" />
<meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1" />
<link rel="shortlink" href="https://www.biorxiv.org/node/1229828" />
    <title>Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo | bioRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__jMRAK66KMC1e4TQlwUNn3KiWVDC5AjueUAYEm1xBY_U__KSUjdT4jdcJ4qJz6fKY1K9WkYh1a5EcaWZxt_-zbTis__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?q8qadd" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__qlYh2rDEXmsOlJKnxoaEiN2PoZU7YzDXSSTk6K1VAQE__XkaAZGAgxyDmOmv0mrGL0sA-jzEgAbgA12amvVPlIf0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__GFpBMW7A95ZNl4oKhiI_0u7WD_8tFHiDfbKIVNkYgis__uourhtZYS_vAk2DtacwQIGmpE376HP4afgwMlmHZpq0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__B6tGdsQSt1vT8d8j-19-oS4FKJe83RrSNBkjPs9jfos__6VkE5WcQmmQpSVTQx-xS2-zn_nlwFlDm-EN1HLJNjrA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__78WRxe8YsWkYp6RcQ_VwTjFG__x9mi_NTPqoxAwFUsA__F3sVKlGyHKCaAPI_WdiHD7l_-05B6b9bLdUwzi1me90__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__dAeSAHswzRXxn-2n4D6zNPmcZDmwaqqLzE-2ab_8jKw__f_9pwrTE8mmshoJRfurwkQ36QonD_Jiwbop2sscnkrE__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/all/libraries/modernizr/modernizr.min.js?q8qadd"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__yOhrJUBmMpN-jsuQlJYmS8ovkQU6I6KInr295HrSTb0__c--zHhbuOWmkdWkJYXiNWDmkpDRPesmbBjGlQcyqBOY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js___KyvuEvfmewWxdOLBXTYsSUo8Pfm_DijV6fWtGvSL_k__HSKkTgIr7nDcdvQYewipf6v4ak6ZLUOQkwPj44wKouA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__OGPr3wJNGw2BAY3Tj6TjIBwKmjQh5i-7muOaPrr0MFA__fCWiU_pDm6xztXUSccH7zrf5422-kgOkuLdWyafrH_0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__hqoKSXYZqkcZkXP--ltzsy0Y3txW5TJBw6HT1khr30Y__6_HqNYoBVMxlkWZwdscqCLCtCxpOhl9_rIOpTDdaI0k__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__lrItkPGmrIuH-E_sdUWEK2i9eTqLar16BAHVxNTWqrc__FhtnljBrjuzYWWrT_f4OYV4jtMBituhMpusb3h0m0rY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-45638026-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__1PtAOZ8x7l6QAi8D7X6Kj_Y7HcUOFzvWRvvYHUcCT98__U8IB92u_CnnGwJ-X_xaUa9lzsC8OzUfN0WkK2JQfirg__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"cPmgHIoSbcgdCw9BHNUFDWeTKRRAwoIO9sL6h8YwAVM","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"modules\/forum\/forum.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/default\/modules\/biorxiv\/css\/biorxiv.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_collection\/css\/highwire_subject_collection.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire.highwire-list-expand.css":1,"public:\/\/ctools\/css\/bab59090150caf0c64e27afa1b36eef1.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"0":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/default\/modules\/jnl_biorxiv_styles\/css\/biorxiv-styles.css.less":1,"https:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"http:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/adv-search-collection-toggle.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/biorxiv-scripts.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/default\/modules\/contrib\/disqus\/disqus.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.highwire-list-expand.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"1229828","apath":"\/biorxiv\/early\/2020\/04\/05\/2020.04.01.019877.atom","pisa":"biorxiv;2020.04.01.019877v1","processed":["highwire_math"],"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"biorxiv;2020.04.01.019877v1"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"biorxivstage","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/2020.04.01.019877v1","title":"Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo","identifier":"node\/1229828"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022dCyW8WF4OZpJLOVbHrfEUwc8AucdY8nZ4WFKrP5lE5XpJll3McFIgGH79Hp1ojLQ0aBM1RYqCW7\\\\\\\/7AZxQrJHDcv8Q3La2\\\\\\\/wN1LYFkcvVfa3+Szc\\\\\\\/Xq8D6BWO5CjtssN5qb467n7fLwDXhbXMJASg8bkKB6IDwwofoidiCW5tAFOmxcQapEXPr3WqG5Tvb7oERiJzmp1zT8ZiRlGDcqMEP6nsDvtI3DKIypo\\\\\\\/lJAMRQsYjiq2S0iVGxMTWYaKqOnoehRJMLdTJtNIOj7Z9qknMX2cMHulgqVtthphL2urRw+aPdQoge5Kt6ocu8yUiYPgB1N5rjtkB+iJvYhc3nf6j1HAuEJyerd5t5XBoMdoIOuqq\\\\\\\/J3XAkkelqsPDisZeDgGuBWK9Pm\\\\\\\/Yh6AINGIgkHvqNyPFvTzM0N3+s2OQOui+iKj\\\\\\\/gxUwYf96xMo\\\\\\\/4xc0XwEhogynci9OpSxOcCQttpSogveTwF0AUR\\\\\\\/wKtPKD9liVEqS4WPSQYdNMh3a8NnxrS9EEsoi\\\\\\\/TT7ZNo5OwGecaZPIqNq0SldWv\\\\\\\/Fa5JKvuBtsWP97rTPS7WyjJTWDAILif\\\\\\\/cCfx6sEgkDPoEal64h8TVJFtwDihYz+nxhlgGN7EvvPtyRsvu+uFWsqXK\\\\\\\/Uib0Dr6KQTeXn3X+V+ziaVPQMjP\\\\\\\/MiXCIfcOH04wWY\\\\\\\/Fud6UVHHjUiaEXLHaEMtwSRmek7ZRp69EfttEqCFpuC9TXea5UwlhFGq26KQNNRjin7jMcay0kVbIRBTQkCVsQPBacPGFat0Z+ocnsdX9c9zPWmLbwZbqnsKGxFGvt4DDkHBpaTS9d32LbE4bvUZy7G4WmZ5C35NZUBrt80OnQ0pKibZurWt6CLffbjn3omWoHXwOhzV1YunpqWzl+dV9sviakGZE8iihq\\\\\\\/5FRJMQsn0LKirEkfe0T25YdXRWcqpevOIpyePOaO\\\\\\\/jOWSpaWR+QXogSt97\\\\\\\/\\\\\\\/bf1dYyWt8rofafzy8P7HsuiQLXR+5nI2zABwJrq1f+RcrAqC6uKEPDZ+uj0\\\\\\\/N7tlI1ZC4AnaoMzvME5mYhfc3P8U5jHYFL3QsrCUyze5SQxE31KM9AYfsw34vh8T3j7B8VV\\\\\\\/dx1ez7Lx5DYDvx1BIQ+GOdjboZEIFQjHwwlJOcbr9gi3JeJ5ADL4MbBpsx2c+oKc++rn17RhzPAgPagSabWdTJ+IqTykEvdjjFGG5hH7ybcSKCA7fK1CTnxfUBMQsGzcdeDBStn5MpbIWqpP96Bn7wim8AYJ3JGlKCg80t0wB8Vnryud4beTC9zJbf3fLLmaW9pRr0a9Xw7DBLmT2UoyXbaQQOpy8vVVyKJikqE8vd0zifER9rkrGif\\\u0022,\\\u0022iv\\\u0022:\\\u0022P7eyMtwMpCEcHj2Y4NKGpQ==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022b8cd0389504530c5fe8156ae8b18d8a23d1d862103d565381a9bfa4af976ba39\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/2020.04.01.019877v1.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.biorxiv.org\/sites\/default\/files\/bioRxiv_article.jpg"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"biorxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-1229828 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-M677548" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="bioRxiv" src="https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/about-biorxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/2020.04.01.019877v1.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-mg82Y_-ZFxH12qt4GUkQcNlbomnAQDbatYs9Z_66ZEE" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="1229828" id="node1229828" data-pisa="biorxiv;2020.04.01.019877v1" data-pisa-master="biorxiv;2020.04.01.019877" data-apath="/biorxiv/early/2020/04/05/2020.04.01.019877.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-top clearfix has-author-tooltip" >

      <span class="biorxiv-article-type">
        New Results    </span>
  
        <h1 class="highwire-cite-title" id="page-title">Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Chunxi</span> <span class="nlm-surname">Zeng</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Xucheng</span> <span class="nlm-surname">Hou</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Jingyue</span> <span class="nlm-surname">Yan</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Chengxiang</span> <span class="nlm-surname">Zhang</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Wenqing</span> <span class="nlm-surname">Li</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Weiyu</span> <span class="nlm-surname">Zhao</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Shi</span> <span class="nlm-surname">Du</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Yizhou</span> <span class="nlm-surname">Dong</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/2020.04.01.019877 </span></div>
  
  
  </div>
<div id="hw-article-author-popups-node1229828" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Chunxi Zeng </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Chunxi%2BZeng%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Zeng%20C&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AChunxi%2BZeng%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Xucheng Hou </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Xucheng%2BHou%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Hou%20X&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AXucheng%2BHou%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Jingyue Yan </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Jingyue%2BYan%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Yan%20J&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJingyue%2BYan%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Chengxiang Zhang </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Chengxiang%2BZhang%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Zhang%20C&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AChengxiang%2BZhang%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Wenqing Li </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Wenqing%2BLi%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Li%20W&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AWenqing%2BLi%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">Weiyu Zhao </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Weiyu%2BZhao%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Zhao%20W&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AWeiyu%2BZhao%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-6"><div class="author-tooltip-name">Shi Du </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Shi%2BDu%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Du%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AShi%2BDu%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-7"><div class="author-tooltip-name">Yizhou Dong </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Division of Pharmaceutics &#38; Pharmacology, College of Pharmacy, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Department of Biomedical Engineering, Center for Clinical and Translational Science, Comprehensive Cancer Center, Dorothy M. Davis Heart &#38; Lung Research Institute, Department of Radiation Oncology, The Ohio State University</span>, Columbus, OH, <span class='nlm-country'>USA</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Yizhou%2BDong%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Dong%20Y&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3AYizhou%2BDong%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:dong.525@osu.edu" class="" data-icon-position="" data-hide-link-title="0">dong.525@osu.edu</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/2020.04.01.019877v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:1229828" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:1229828/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.04.01.019877v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:1229828" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:1229828/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.04.01.019877v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:1229828" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:1229828/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.04.01.019877v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:1229828" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:1229828/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.04.01.019877v1.supplementary-material" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:1229828" data-trigger="supplementary-material" data-url-enabled="1">Supplementary material</a><a href="/panels_ajax_tab/biorxiv_tab_data/node:1229828/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/2020.04.01.019877v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:1229828" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:1229828/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-article_tab_full_text"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">Abstract</h2><p id="p-2">SARS-CoV-2 has rapidly become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as a promising platform for vaccination. Here, we systematically investigated the untranslated regions (UTRs) of mRNAs in order to enhance protein production. Through a comprehensive analysis of endogenous gene expression and de novo design of UTRs, we identified the optimal combination of 5’ and 3’ UTR, termed as NASAR, which was five to ten-fold more efficient than the tested endogenous UTRs. More importantly, NASAR mRNAs delivered by lipid-derived nanoparticles showed dramatic expression of potential SARS-CoV-2 antigens both in vitro and in vivo. These NASAR mRNAs merit further development as alternative SARS-CoV-2 vaccines.</p></div><div class="section" id="sec-1"><h2 class="">Introduction</h2><p id="p-3">SARS-CoV-2, a novel coronavirus, is causing a global pandemic, leading to over 900,000 confirmed cases and 45,000 death as of April 1, 2020<sup><a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a></sup>. SARS-CoV-2 shares 79% sequence identity with SARS-CoV and infects host cells through the receptor of angiotensin-converting enzyme 2<sup><a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a></sup>. To counteract this severe viral infection, a wide variety of therapeutics are in preclinical and clinical studies<sup><a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a></sup>. Currently, there is no FDA-approved treatment for SARS-CoV-2 infection.</p><p id="p-4">Vaccine is the most effective strategy to prevent viral infections for a large population<sup><a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a></sup>. Different types of SARS-CoV-2 vaccines such as mRNA, DNA, and recombinant protein-based antigens are currently in clinical trials<sup><a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a></sup>. Among these agents, mRNA-based vaccine candidates first entered the clinical trial, because of the fast process for developing and manufacturing mRNA<sup><a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a></sup>. To express an antigen effectively, an mRNA requires several essential components, including 5’ cap, 5’ untranslated region (5’ UTR), antigen-encoding sequence, 3’ untranslated region (3’ UTR), and polyadenylated tail<sup><a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a></sup>. Among these components, the 5’ UTR and 3’ UTR are unique regulators for protein translation<sup><a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a></sup>. The design and selection of 5’ UTR and 3’ UTR are critically important to ensure the sufficient production of antigens and efficacious vaccination of the host<sup><a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a></sup>. Therefore, systematic explorations of UTRs may provide broad applicability for mRNA vaccines in response to emerging pathogens such as SARS-CoV-2. Previous studies utilized many UTRs from endogenous genes for protein expression<sup><a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a></sup>. For example, the UTRs from human cytochrome B-245 alpha polypeptide (CYBA) outperformed several other UTRs for protein expression<sup><a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a></sup>. The 5’ UTR from alpha globin mRNA enabled higher translation efficiency than that from beta globin mRNA in cells<sup><a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a></sup>. Alternatively, UTRs can be designed via a de novo method. A recent study reported a series of 5’UTRs consisting of 12-14 nucleotides (nt)<sup><a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a></sup>. Also, a deep learning method was applied to screen and analyze a large set of 5’UTRs<sup><a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a></sup>. Based on these significant advances, we hypothesize that the integration of endogenous UTRs with further de novo design may be a superior approach for UTRs engineering, facilitating the development of SARS-CoV-2 vaccines (<strong><a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1</a></strong>). Our results prove the concept of this approach and significantly increase protein production compared to the UTRs reported in the literatures<sup><a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">12</a>, <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>-<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a></sup>. Lastly, a series of potential SARS-CoV-2 antigens are visualized via fluorescent imaging in both cell and animal models, which may serve as vaccine candidates for the clinical trials.</p><div id="F1" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Schematic illustration of mRNA engineering. 5&#x2019; UTR and 3&#x2019; UTR of mRNA are comprehensively modulated based on the analysis of endogenous genes and further de novo design in order to enrich protein production and express SARS-CoV-2 antigens as potential vaccines." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-46317324" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;Schematic illustration of mRNA engineering. 5&#x2019; UTR and 3&#x2019; UTR of mRNA are comprehensively modulated based on the analysis of endogenous genes and further de novo design in order to enrich protein production and express SARS-CoV-2 antigens as potential vaccines.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F1.medium.gif" width="440" height="99"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F1.medium.gif" width="440" height="99"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">Figure 1.</span> <p id="p-5" class="first-child">Schematic illustration of mRNA engineering. 5’ UTR and 3’ UTR of mRNA are comprehensively modulated based on the analysis of endogenous genes and further de novo design in order to enrich protein production and express SARS-CoV-2 antigens as potential vaccines.</p><div class="sb-div caption-clear"></div></div></div></div><div class="section" id="sec-2"><h2 class="">Results</h2><div id="sec-3" class="subsection"><h3>Investigation of endogenous 5’ UTR and 3’ UTR</h3><div id="sec-4" class="subsection"><h4>Endogenous 5’ UTR from bioinformatics analysis</h4><p id="p-6">To screen endogenous UTRs in mammalian cells, we utilized a bioinformatics analysis of global gene expression as a starting point. Previously, the average half-life (h) and translation rate constant [protein copy number/(mRNA×h)] of 4248 mRNAs and corresponding proteins were quantified in mammalian cells<sup><a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a></sup>. According to their data, we calculated the translation capacity per mRNA molecule using the following equation: average half-life (h) × translation rate constant [protein copy number/(mRNA×h)] × protein length (amino acids) = translation capacity per mRNA molecule (total amino acids/mRNA) (<strong>Supplementary Table 1</strong>). These results indicated the number of amino acids produced by a single mRNA during its half-life. The mRNA from the murine Rps27a gene was found to possess the highest translation capacity per mRNA molecule. Rps27a is a housekeeping gene that encodes one of the components of the ribosome 40S subunit<sup><a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a></sup>. Two protein-coding transcripts exist for the murine Rps27a gene (named S27a-44 and S27a-45). These two transcripts have different 5’ UTRs and share the same 3’ UTR (<strong>Supplementary Table 2</strong> and <strong>Supplementary Table 3</strong>). Therefore, we generated two mRNAs utilizing S27a-45 and S27a-44 5’ UTRs, respectively. In these two 5’ UTRs, we found putative terminal oligo-pyrimidine (TOP) motifs consisting of 4-15 clustered pyrimidines (C and U), which were reported to negatively regulate mRNA translation (<strong>Supplementary Table 2</strong>)<sup><a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a></sup>. Subsequently, we removed the TOP motifs from S27a-44 and S27a-45 5’ UTRs and constructed two additional 5’ UTRs: S27a-44’ and S27a-45’. The mRNAs encoding Firefly luciferase were synthesized with these 5’ UTRs and were delivered to Hep3B and 293T cells using lipofectamine 3000. The control UTRs include CYBA UTRs (named CYBA)<sup><a id="xref-ref-12-3" class="xref-bibr" href="#ref-12">12</a></sup>, alpha globin UTRs (named AG)<sup><a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a></sup>, and modified alpha globin UTRs (AG+G with a complete Kozak sequence and 5AG+G without 3’ UTR)<sup><a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a></sup>. 5’ UTR from S27a-44 was better than that from S27a-45 (<strong><a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 2a</a></strong>). Removal of the putative TOP motif from S27a-45 moderately improved expression, while S27a-44’ without the TOP motif increased the relative luciferase activity over 70% compared to the S27a-44 in the two cell lines. S27a-44’ was comparable to CYBA and AG+G, the two best controls (<strong><a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 2a</a></strong>).</p><div id="F2" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Evaluation of endogenous 5&#x2019; and 3&#x2019; UTRs. a, Relative luciferase activity in Hep 3B and 293 T cells. Four different 5&#x2019; UTR in blue are assessed with the same 3&#x2019; UTR. b, Relative luciferase activity in Hep 3B and 293T cells. Four different 3&#x2019; UTR in green are assessed with the same 5&#x2019; UTR. Control UTRs are in grey. Relative luciferase activity was normalized to that of CYBA. All data are presented as the mean &#xB1; s.d. (n=4)." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-46317324" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;Evaluation of endogenous 5&#x2019; and 3&#x2019; UTRs. &lt;strong&gt;a&lt;/strong&gt;, Relative luciferase activity in Hep 3B and 293 T cells. Four different 5&#x2019; UTR in blue are assessed with the same 3&#x2019; UTR. &lt;strong&gt;b&lt;/strong&gt;, Relative luciferase activity in Hep 3B and 293T cells. Four different 3&#x2019; UTR in green are assessed with the same 5&#x2019; UTR. Control UTRs are in grey. Relative luciferase activity was normalized to that of CYBA. All data are presented as the mean &#xB1; s.d. (n=4).&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F2.medium.gif" width="440" height="126"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F2.medium.gif" width="440" height="126"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 2.</span> <p id="p-7" class="first-child">Evaluation of endogenous 5’ and 3’ UTRs. <strong>a</strong>, Relative luciferase activity in Hep 3B and 293 T cells. Four different 5’ UTR in blue are assessed with the same 3’ UTR. <strong>b</strong>, Relative luciferase activity in Hep 3B and 293T cells. Four different 3’ UTR in green are assessed with the same 5’ UTR. Control UTRs are in grey. Relative luciferase activity was normalized to that of CYBA. All data are presented as the mean ± s.d. (n=4).</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-5" class="subsection"><h4>Comparison study of endogenous 3’ UTR</h4><p id="p-8">We next compared 3’ UTR of the S27a with three alternative UTRs. Two 3’ UTRs were obtained from the mRNAs of transferrin (TF) and α-1-antitrypsin (AAT), two abundant human plasma proteins<sup><a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a></sup>. Another 3’ UTR from Hepatitis C viral RNA (HCV) was reported to retain and recycle the 40S subunit of ribosome after translation termination at stop codon, accelerating re-initiation of translation<sup><a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a></sup>. We then constructed these 3’ UTRs with the same 5’ UTR. As shown in <strong><a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2b</a></strong>, these UTRs displayed similar effects on luciferase expression. Additionally, replacing S27a 3’UTR with another unstructured 3’ UTR of the same length significantly decreased protein expression (<strong>Supplementary Table 3</strong> and <strong>Supplementary Fig. 1</strong>). Since the length of S27a 3’ UTR (34nt) was considerably shorter than other 3’ UTRs (AAT 100nt, TF 386nt, or HCV 190nt), S27a 3’ UTR was used in the following studies.</p></div></div><div id="sec-6" class="subsection"><h3>De novo design and optimization of 5’ UTR</h3><div id="sec-7" class="subsection"><h4>Explorations of 5’ UTR length</h4><p id="p-9">Besides utilizing UTRs derived from endogenous genes, one alternative approach is to design mRNA UTRs via a de novo method, which is widely applied in protein engineering<sup><a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a></sup>. During the process of de novo design for UTRs, several general principles can be considered. For example, the Kozak sequence (GCCACC) located directly upstream of the translation start codon (AUG) can be included because it is a conserved sequence among many mammalian mRNAs for accurate start codon recognition<sup><a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a></sup>. Second, AUG within 5’ UTR is excluded to avoid alternative translation initiation and mutation of the amino acid sequence<sup><a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a></sup>. Third, secondary structures may be minimized to reduce the energy barriers for smooth scanning of the translation initiation complex along the 5’ UTR<sup><a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>, <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a></sup>. Based on the knowledge in the literature, we designed 5’ UTR of different length: 10nt, 30, 50nt, 70nt, and 90nt with minimal secondary structures as modeled by RNAfold, a well-established computational tool for the prediction of RNA secondary structures (<strong>Supplementary Fig. 2a</strong> and <strong>Supplementary Table 2</strong>). We then prepared the mRNAs and evaluated their luciferase expression as mentioned above. The results showed that relative luciferase activity increased with 5’ UTR length and peaked at 70nt (<strong><a id="xref-fig-3-1" class="xref-fig" href="#F3">Fig. 3a</a></strong>). Further increase of the length lowered luciferase expression. Therefore, 70nt was used as the optimal length for the subsequent design of 5’UTRs.</p><div id="F3" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="De novo design and engineering of 5&#x2019; UTR. a, Relative luciferase activity of mRNAs with 5&#x2019; UTRs consisting of 10nt, 30nt, 50nt, 70nt, or 90nt in Hep 3B and 293T cells. b, Relative luciferase activity of mRNA with different nucleotide compositions of 5&#x2019; UTRs in Hep 3B and 293T cells. c, Relative luciferase activity after removal of miRNA target sites in 5&#x2019; UTR. NCA-7d and NCA-8d: removal of miRNA binding sites from NCA-7 and NCA-8, respectively. Relative luciferase activity was normalized to that of CYBA. All data are presented as the mean &#xB1; s.d. (n=4)." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-46317324" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;De novo design and engineering of 5&#x2019; UTR. &lt;strong&gt;a&lt;/strong&gt;, Relative luciferase activity of mRNAs with 5&#x2019; UTRs consisting of 10nt, 30nt, 50nt, 70nt, or 90nt in Hep 3B and 293T cells. &lt;strong&gt;b&lt;/strong&gt;, Relative luciferase activity of mRNA with different nucleotide compositions of 5&#x2019; UTRs in Hep 3B and 293T cells. &lt;strong&gt;c&lt;/strong&gt;, Relative luciferase activity after removal of miRNA target sites in 5&#x2019; UTR. NCA-7d and NCA-8d: removal of miRNA binding sites from NCA-7 and NCA-8, respectively. Relative luciferase activity was normalized to that of CYBA. All data are presented as the mean &#xB1; s.d. (n=4).&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F3.medium.gif" width="289" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 3." src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F3.medium.gif" width="289" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 3.</span> <p id="p-10" class="first-child">De novo design and engineering of 5’ UTR. <strong>a</strong>, Relative luciferase activity of mRNAs with 5’ UTRs consisting of 10nt, 30nt, 50nt, 70nt, or 90nt in Hep 3B and 293T cells. <strong>b</strong>, Relative luciferase activity of mRNA with different nucleotide compositions of 5’ UTRs in Hep 3B and 293T cells. <strong>c</strong>, Relative luciferase activity after removal of miRNA target sites in 5’ UTR. NCA-7d and NCA-8d: removal of miRNA binding sites from NCA-7 and NCA-8, respectively. Relative luciferase activity was normalized to that of CYBA. All data are presented as the mean ± s.d. (n=4).</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-8" class="subsection"><h4>Nucleotide composition analysis of 5’ UTR</h4><p id="p-11">In addition to length, nucleotide compositions of A, C, G, and U may be an important factor at the 5’ UTR. Generally, high GC content is commonly associated with increased structural complexity<sup><a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a></sup>. G can base pair with both C and U and induce the formation of more secondary structures<sup><a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a></sup>. The increase of U content may introduce additional chemically modified nucleotides into 5’ UTR if modified U, such as pseudouridine are used in mRNA synthesis. To understand the effects of nucleotide compositions, we performed nucleotide compositions analysis and designed a series of 5’ UTRs (NCA-1 to NCA-8). When adjusting nucleotide composition, the minimal numbers of G and C are 3 and 4, respectively, due to the transcription start site determined by the T7 promoter sequence (GG) and the use of Kozak sequence (GCCACC). These 5’ UTRs were also built to avoid secondary structures (<strong>Supplementary Fig. 2b</strong>), thereby minimizing the impact of structures on translation initiation. As shown in <strong><a id="xref-fig-3-2" class="xref-fig" href="#F3">Fig. 3b</a></strong>, a decrease of relative luciferase activity was observed with less A and more G when the amount of C and U were constant (NCA-1 vs NCA-2; NCA-1 vs NCA-3). When G and U were minimal, the increase of C and decrease of A content showed a moderate decrease of luciferase expression (NCA-3 vs NCA-4). When holding G content to the minimal of 3, the inclusion of U boosted relative luciferase activity (NCA-5 vs NCA-6 vs NCA-7 vs NCA-8). Moreover, these 5’ UTR with ACU outperformed those consisting of mostly AC and AG, suggesting the importance of U on 5’ UTR. Consequently, two constructs with high U contents, NCA-7 and NCA-8, were selected for further studies.</p></div><div id="sec-9" class="subsection"><h4>Removal of microRNA target sites from 5’ UTR</h4><p id="p-12">MicroRNAs were previously considered to mainly target the 3’ UTR of mRNA for gene regulations<sup><a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a></sup>. However, recent data showed that miRNAs also interfered with ribosomal scanning by binding to target sites within 5’ UTR<sup><a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a></sup>. Hence, we examined possible miRNA target sites within NCA-7 and NCA-8 using the prediction tool available at miRDB. The prediction exhibited that both NCA-7 and NCA-8 contained miRNA target sites (<strong>Supplementary Table 2</strong>). Then, we adjusted the order of the nucleotides of NCA-7 and NCA-8 and created NCA-7d and NCA-8d, which maintain their nucleotide compositions with minimal secondary structure. Interestingly, NCA-7d showed a slightly increased expression than NCA-7, while NCA-8d was less active than NCA-8 (<strong><a id="xref-fig-3-3" class="xref-fig" href="#F3">Fig. 3c</a></strong>). Based on these results, NCA-7d was selected as the lead 5’ UTR.</p></div><div id="sec-10" class="subsection"><h4>Optimization of 3’ UTR with integrated motifs</h4><p id="p-13">Next, we further studied the effects of functional motifs integrated with the lead S27a 3’ UTR. Previous studies reported that abundant cis-regulatory elements existed in mRNA 3’ UTR to modulate protein expression, such as functional motifs for RNA binding proteins (RBPs)<sup><a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">11</a></sup>. Specific RBPs are able to bind to their cognate motifs within mRNA 3’ UTR and enhance protein expression through various mechanisms<sup><a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a></sup>. One of the RBPs, QKI-7, was shown to enable cytoplasmic polyadenylation of mRNA and upregulation of protein expression after binding to its target motif called QKI Response Element (QRE) in 3’ UTR<sup><a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a></sup>. Two QRE sequences were obtained from previous reports, namely QRE1<sup><a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a></sup> and QRE2<sup><a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a></sup>. Another RBP, HuR, was believed to stabilize target transcripts by binding to its cognate motifs called AU-Rich Element (ARE) in eukaryotic cells<sup><a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a></sup>. One such ARE sequence was obtained from human eIF4E mRNA 3’ UTR<sup><a id="xref-ref-34-2" class="xref-bibr" href="#ref-34">34</a></sup>. Besides eukaryotic mRNA, the sindbis virus (SinV) evolved to utilize part of its viral 3’ UTR to recruit HuR and induce potent stabilization of the viral RNA genome<sup><a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a></sup>. The SinV RNA regions responsible for HuR binding, including repeated sequence element 3 and U-rich element (together named R3U) was obtained. Additionally, the ribosome binding fragments from two internal ribosome entry sites (IRESs) of encephalomyocarditis virus (EMCV)<sup><a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a></sup> and foot-and-mouth disease virus (FMDV)<sup><a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a></sup> were selected. These two fragments possess high binding affinities to ribosomal subunits and have the potential to retain and recycle the subunits for more efficient translation re-initiation. Based on these literature findings, we prepared mRNA transcripts with the integration of the following elements after S27a 3’ UTR: QRE1, QRE2, R3U, ARE, EMCV, and FMDV (<strong>Supplementary Table 3</strong>). R3U was identified as a preferred functional motif from the results in both Hep3B and 293T cells (<strong><a id="xref-fig-4-1" class="xref-fig" href="#F4">Fig. 4a</a></strong>). Through the comprehensive UTR engineering, the optimal UTRs was identified as NCA-7d as the 5’ UTR and S27a plus a functional motif R3U as the 3’ UTR (named as NASAR). After several rounds of design and validation of UTRs, we then compared NASAR with S27a-45, the starting point of endogenous gene together with two additional control UTRs (MOD1 and MOD2) in the literature<sup><a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a>, <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a></sup>. NASAR was over 10-fold more potent than S27a-45, 4 to 7-fold better than CYBA or AG+G, and up to 2-fold superior to MOD1 and MOD2 in cell lines and primary cells (<strong><a id="xref-fig-4-2" class="xref-fig" href="#F4">Fig. 4b</a></strong> and <strong>Supplementary Fig. 3</strong>). These results demonstrate that our concept, integration of endogenous UTRs with further de novo design, is an efficient strategy for UTRs design.</p><div id="F4" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Modifications of 3&#x2019; UTR. a, Relative luciferase activity of mRNAs with addition of RNA motifs after S27a 3&#x2019; UTR. No motif: S27a 3&#x2019; UTR only. All engineered mRNAs in green utilized the same 5&#x2019; UTR. b, Relative luciferase activity of NASAR mRNAs in comparison to S27a-45, a start UTR, and additional control UTRs, MOD1 and MOD2. Relative luciferase activity was normalized to that of S27a-45. All data are presented as the mean &#xB1; s.d. (n=4). Statistical significance in a and b was analyzed by the two-tailed Student&#x2019;s t-test. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; n.s., not significant." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-46317324" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;Modifications of 3&#x2019; UTR. &lt;strong&gt;a&lt;/strong&gt;, Relative luciferase activity of mRNAs with addition of RNA motifs after S27a 3&#x2019; UTR. No motif: S27a 3&#x2019; UTR only. All engineered mRNAs in green utilized the same 5&#x2019; UTR. &lt;strong&gt;b&lt;/strong&gt;, Relative luciferase activity of NASAR mRNAs in comparison to S27a-45, a start UTR, and additional control UTRs, MOD1 and MOD2. Relative luciferase activity was normalized to that of S27a-45. All data are presented as the mean &#xB1; s.d. (n=4). Statistical significance in a and b was analyzed by the two-tailed Student&#x2019;s t-test. *&lt;em&gt;P&lt;/em&gt; &lt; 0.05; **&lt;em&gt;P&lt;/em&gt; &lt; 0.01; ***&lt;em&gt;P&lt;/em&gt; &lt; 0.001; n.s., not significant.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F4.medium.gif" width="440" height="134"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 4." src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F4.medium.gif" width="440" height="134"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 4.</span> <p id="p-14" class="first-child">Modifications of 3’ UTR. <strong>a</strong>, Relative luciferase activity of mRNAs with addition of RNA motifs after S27a 3’ UTR. No motif: S27a 3’ UTR only. All engineered mRNAs in green utilized the same 5’ UTR. <strong>b</strong>, Relative luciferase activity of NASAR mRNAs in comparison to S27a-45, a start UTR, and additional control UTRs, MOD1 and MOD2. Relative luciferase activity was normalized to that of S27a-45. All data are presented as the mean ± s.d. (n=4). Statistical significance in a and b was analyzed by the two-tailed Student’s t-test. *<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01; ***<em>P</em> &lt; 0.001; n.s., not significant.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-11" class="subsection"><h4>NASAR mRNAs express SARS-CoV-2 antigens</h4><p id="p-15">Given the potent activity of NASAR mRNAs and urgent demand for SARS-CoV-2 vaccines, we aim to create NASAR mRNAs encoding SARS-CoV-2 antigens. According to previous studies on SARS-CoV, its structural spike (S) and nucleocapsid (N) proteins, regarded as the dominant antigens eliciting neutralizing antibodies in SARS-CoV patients, were explored as vaccine candidates<sup><a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>, <a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a></sup>. The receptor binding domain (RBD) of the S protein responsible for viral entry was also utilized for vaccine development<sup><a id="xref-ref-38-2" class="xref-bibr" href="#ref-38">38</a></sup>. The membrane (M) protein contained epitopes<sup><a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a></sup>. Additionally, the envelope (E) protein interacting with M was indispensable for the assembly of viral particles<sup><a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">41</a></sup>. Therefore, five NASAR mRNAs were prepared to express RBD, S, N, M, and E proteins as the vaccine candidates. Since no antibodies have been developed against these five potential antigens in SARS-CoV-2, we installed a FLAG tag to RBD andS protein, and a VSV-G tag to N, M, and E proteins in order to detect their expression. To confirm the effects of UTRs on antigen expression using NASAR mRNA vaccine, three additional mRNAs were synthesized using the coding sequence of RBD with control UTRs, CYBA, MOD2, and NASAR. After the delivery of these three mRNAs into 293T cells using our previously developed lipid like-nanoparticles, TT3<sup><a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a></sup>, RBD expression was analyzed by an ELISA. NASAR enabled antigen expression 3-fold of CYBA and 1.6-fold of MOD2 (<strong><a id="xref-fig-5-1" class="xref-fig" href="#F5">Fig. 5a</a></strong>), consistent with the luciferase expression results in <strong><a id="xref-fig-4-3" class="xref-fig" href="#F4">Fig. 4c</a></strong>. Then, NASAR mRNAs encoding all five SARS-CoV-2 antigens were delivered to 293T cells by TT3 separately. We observed the obvious expression of these antigens through immunostaining (<strong><a id="xref-fig-5-2" class="xref-fig" href="#F5">Fig. 5b</a>, Supplementary Fig. 4</strong>).</p><div id="F5" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F5.large.jpg?width=800&amp;height=600&amp;carousel=1" title="NASAR mRNAs encoding potential SARS-CoV-2 antigens. a, Relative RBD antigen level in 293T cells quantified by ELISA (n=3). b, Fluorescent microscopy imaging of S and RBD antigens in 293T cells. Scale bar = 100&#xB5;m. c, Quantification of luciferase expression in vivo after i.m. injection to mice. MC3-NASAR luciferase and TT3-NASAR luciferase mRNAs (n=6). d, Confocal microscopy imaging of S and RBD antigens expressed in mouse muscle tissues after i.m. injection. Scale bar = 100&#xB5;m. All data are presented as the mean &#xB1; s.d. Statistical significance in a and c was analyzed by the two-tailed Student&#x2019;s t-test. **P &lt; 0.01; ***P &lt; 0.001." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-46317324" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;NASAR mRNAs encoding potential SARS-CoV-2 antigens. &lt;strong&gt;a&lt;/strong&gt;, Relative RBD antigen level in 293T cells quantified by ELISA (n=3). &lt;strong&gt;b&lt;/strong&gt;, Fluorescent microscopy imaging of S and RBD antigens in 293T cells. Scale bar = 100&#xB5;m. &lt;strong&gt;c&lt;/strong&gt;, Quantification of luciferase expression in vivo after i.m. injection to mice. MC3-NASAR luciferase and TT3-NASAR luciferase mRNAs (n=6). &lt;strong&gt;d&lt;/strong&gt;, Confocal microscopy imaging of S and RBD antigens expressed in mouse muscle tissues after i.m. injection. Scale bar = 100&#xB5;m. All data are presented as the mean &#xB1; s.d. Statistical significance in a and c was analyzed by the two-tailed Student&#x2019;s t-test. **&lt;em&gt;P&lt;/em&gt; &lt; 0.01; ***&lt;em&gt;P&lt;/em&gt; &lt; 0.001.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F5.medium.gif" width="440" height="149"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 5." src="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F5.medium.gif" width="440" height="149"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 5." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/05/2020.04.01.019877/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 5.</span> <p id="p-16" class="first-child">NASAR mRNAs encoding potential SARS-CoV-2 antigens. <strong>a</strong>, Relative RBD antigen level in 293T cells quantified by ELISA (n=3). <strong>b</strong>, Fluorescent microscopy imaging of S and RBD antigens in 293T cells. Scale bar = 100µm. <strong>c</strong>, Quantification of luciferase expression in vivo after i.m. injection to mice. MC3-NASAR luciferase and TT3-NASAR luciferase mRNAs (n=6). <strong>d</strong>, Confocal microscopy imaging of S and RBD antigens expressed in mouse muscle tissues after i.m. injection. Scale bar = 100µm. All data are presented as the mean ± s.d. Statistical significance in a and c was analyzed by the two-tailed Student’s t-test. **<em>P</em> &lt; 0.01; ***<em>P</em> &lt; 0.001.</p><div class="sb-div caption-clear"></div></div></div><p id="p-17">Based on the encouraging cell results, we performed intramuscular (i.m.) injection, a widely used administration route for vaccines<sup><a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">43</a></sup>, of NASAR mRNAs. Similar to in vitro results, NASAR was 4.2-fold more potent than CYBA in the luciferase expression when both were delivered by TT3 nanoparticles (<strong>Supplementary Fig. 5</strong>). Moreover, TT3 nanoparticles induced over 70-fold more luciferase activity than MC3 nanoparticles, an FDA-approved delivery vehicle<sup><a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a>, <a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">45</a></sup>, when formulated with the same NASAR mRNAs (<strong><a id="xref-fig-5-3" class="xref-fig" href="#F5">Fig. 5c</a></strong>). Lastly, NASAR mRNAs encoding either RBD or S protein were formulated with TT3 and injected intramuscularly into hind legs of mice. Confocal microscopy imaging of the mouse tissues with immunostaining confirmed the expression of both antigens (<strong><a id="xref-fig-5-4" class="xref-fig" href="#F5">Fig. 5d</a></strong>).</p></div></div></div><div class="section" id="sec-12"><h2 class="">Discussion</h2><p id="p-18">This study describes a rational engineering approach to enhance protein production using mRNA. Through bioinformatics analysis and modification of endogenous 5’ UTR and 3’ UTR, followed by de novo design and further optimization, the most effective NASAR UTR was identified, enabling strong expression of multiple potential SARS-CoV-2 antigens both in vitro and in vivo.</p><p id="p-19">Based on this study, several criteria should be considered in the design of mRNA UTRs: (1). Regarding the 5’ UTR, the length is critical and the optimal sequences tested in this work do not exceed 70nt. And it should be free of certain regulatory elements, e.g. TOP motifs, secondary structure, upstream open reading frame, and microRNA binding site. (2). In terms of 3’ UTR, secondary structures may benefit protein production. A plausible explanation is that such structure in 3’ UTR might prevent ribosome from skipping the stop codon and reaching mRNA 3’ end that triggers Non-Stop mRNA Decay (NSD)<sup><a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46</a></sup>. Long 3’ UTR length does not necessarily provide additional translation benefits. Long 3’ UTR typically contains a mixture of positive and negative cis-regulatory elements<sup><a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">11</a></sup>. Although it is challenging to obtain a long endogenous 3’ UTR with only positive elements, specific positive cis-regulatory motifs in 3’ UTRs may be used to improve mRNA translation. R3U, a HuR binding motif added to 3’ UTR, enhanced protein expression, consistent with the observation in their natural context<sup><a id="xref-ref-34-3" class="xref-bibr" href="#ref-34">34</a>, <a id="xref-ref-35-2" class="xref-bibr" href="#ref-35">35</a></sup>. This indicates that certain positive cis-regulatory elements may be used as an important UTR component.</p><p id="p-20">In order to cope with the current SARS-CoV-2 pandemic, NASAR mRNAs can be applied to encode various SARS-CoV-2 antigens. Importantly, TT3 formulated NASAR Fluc mRNA was much more efficient for than an FDA-approved delivery system MC3. This enables us to combine the strength of NASAR mRNAs and TT3 nanoparticles to maximize the expression of SARS-CoV-2 antigens. Overall, this work provides a proof-of-concept study to develop mRNA vaccine candidates against SARS-CoV-2, which may be conducive to clinical translations.</p></div><div class="section" id="sec-13"><h2 class="">Methods</h2><div id="sec-14" class="subsection"><h3>Chemicals and reagents</h3><p id="p-21">Opti-MEM Reduced Serum Medium was purchased from Thermo Fisher Scientific. Cell culture plates and luminescent assay plates were obtained from Corning. MC3 was purchased from MedKoo. DOPE and DMG-PEG2000 were purchased from Avanti Polar Lipids. Cholesterol was obtained from Sigma-Aldrich. Q5 High-Fidelity PCR Kit was purchased from NEB.</p></div><div id="sec-15" class="subsection"><h3>De novo design of 5’ UTR</h3><p id="p-22">5’ UTRs were designed de novo using AntaRNA (<a href="http://rna.informatik.uni-freiburg.de">http://rna.informatik.uni-freiburg.de</a>) <sup><a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">47</a></sup> with predefined nucleotide composition as the sequence constrain and minimal secondary structure as the structural constrain. GU base pairs were permitted. The secondary structure of the output sequences was further confirmed by RNAfold (<a href="http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi">http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi</a>). Sequences with undesired secondary structures were discarded. The microRNA binding sites within 5’ UTR were predicted using the custom prediction tool in the microRNA database (miRDB) (<a href="http://mirdb.org/">http://mirdb.org/</a>)<sup><a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">48</a></sup>. Due to the minimum size limit of 100nt for mRNA target submission, the full 5’ UTR and first 100 nucleotides of the firefly luciferase coding region were used as the input sequences.</p></div><div id="sec-16" class="subsection"><h3>Plasmid construction</h3><p id="p-23">The sequences necessary for in vitro transcription of mRNA, including T7 promoter, 5’ UTR, coding sequence, and 3’ UTR, were cloned into pUC19 vector using repliQa HiFi Assembly Mix (QuantaBio) and transformed into 5-alpha Competent E. coli (NEB) by chemical transformation. The transformed E. coli was allowed to grow on LB broth (Miller) plate with agar and 100ug/mL carbenicillin (Teknova). Individual colonies were inoculated and outgrown in LB broth liquid medium (Miller) containing 100ug/mL carbenicillin overnight with vigorous shaking at 250 rpm. Plasmids were extracted using QIAprep Spin Miniprep Kit (Qiagen). Concentration was measured on a NanoDrop 2000 Spectrophotometer (Thermo). The region of interest in the plasmid from the T7 promoter to 3’ UTR was confirmed by Sanger Sequencing.</p></div><div id="sec-17" class="subsection"><h3>mRNA synthesis</h3><p id="p-24">All mRNA transcripts were synthesized by in vitro transcription using a protocol modified from our previous publication<sup><a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a></sup>. Briefly, DNA templates were synthesized by PCR amplification of the corresponding plasmids using a forward primer and a reverse primer containing 120T at 5’ end. The DNA templates were purified by QIAquick PCR Purification Kit (Qiagen) and examined by agarose gel electrophoresis. All mRNAs were synthesized by in vitro transcription with 100% substitution of UTP by pseudouridine-5’-triphosphate (TriLink) using AmpliScribe T7-Flash Transcription Kit (Lucigen) following the manufacturer’s instruction and purified by RNA Clean &amp; Concentrator (Zymo). The capping of mRNA was conducted using Vaccinia Capping System (NEB) and Cap 2’-O-Methyltransferase (NEB), followed by another purification by RNA Clean &amp; Concentrator (Zymo). After measurement of concentration by a NanoDrop 2000 Spectrophotometer (Thermo), all mRNAs were diluted to the desired concentration in 1× TE, aliquoted, and stored at -80°C for future use.</p></div><div id="sec-18" class="subsection"><h3>Firefly luciferase assay in vitro</h3><p id="p-25">Hep3B and 293T cells were cultured in Eagle’s Minimum Essential Medium (Corning) with 10% Fetal Bovine Serum (FBS) and Dulbecco’s Modified Eagle Medium (Corning) with 10% FBS, respectively. Hep3B and 293T cells were seeded at a density of 2×10<sup>4</sup> cells/well on a white 96-well flat-bottom plate (Costar) followed by overnight incubation. The mRNAs were thawed on ice and denatured at 65°C for 3min followed by incubation at room temperature for 45min. When Lipofectamine 3000 (Thermo) was used, the transfection was performed according to the manufacturer’s instruction. When TT3 nanoparticles was used, mRNA was formulated using lipid:DOPE:cholesterol:DMG-PEG2000 at a molar ratio of 20:30:40:0.75 as reported before.<sup><a id="xref-ref-42-2" class="xref-bibr" href="#ref-42">42</a></sup> Then, cells in each well were treated with 50 ng per well of Firefly luciferase mRNA. The luminescence activity was determined on a Cytation 5 Cell Imaging Multi-Mode Reader (Biotek) using a Bright-Glo Luciferase Assay Kit (Promega).</p></div><div id="sec-19" class="subsection"><h3>Quantification of RBD levels with ELISA</h3><p id="p-26">1 × 10<sup>5</sup> 293T cells were seeded in each well in a 24-well plate and grew overnight. The cells were treated with 100 ng per well mRNAs encoding the RBD antigen using TT3 nanoparticles as mentioned above. After overnight incubation, cells were lysed in each well. The cell lysis was retrieved and centrifuged at 12000×rpm for 10min. EZview Red ANTI-FLAG M2 Affinity Gel was used to concentrate the FLAG-tagged RBD in the pellet following the manufacturer’s protocol. RBD was eluted into 0.1M glycine HCl at pH 3.5 and diluted 10 times before coating a 96-well immunoplate (Thermo/Nunc). After blocking, primary rabbit anti-FLAG antibody (ab1162, abcam) at 1:1000 dilution was added, followed by incubation with HRP-linked anti-rabbit IgG (Cell Signaling, 7074). OD492 reading was obtained on a Cytation 5 Cell Imaging Multi-Mode Reader (Biotek).</p></div><div id="sec-20" class="subsection"><h3>Immunostaining and microscopy imaging</h3><p id="p-27">293T cells were grown overnight on cover slides placed in a 6-well plate. TT3 nanoparticles were formulated with mRNAs encoding SARS-CoV-2 antigens, S, RBD, M, N, and E proteins, as described above. Six hours after treatment, cells were washed with phosphate buffered saline (PBS) and fixed with 10% formalin, followed by permeabilization with 0.2% Tween-20. Staining was conducted using primary rabbit anti-FLAG antibody (abcam, ab1162) at 1:200 dilution and FITC-linked secondary goat anti-rabbit polyclonal antibody (abcam, ab6717) at 1:1000 dilution. Nucleus was stained with Hoechst 33342 (Thermo). After sealing the slides, images were taken on a Nikon Eclipse Ti Inverted Fluorescence Phase Contrast Microscope with NIS-Elements BR imaging software (version 4.20).</p></div><div id="sec-21" class="subsection"><h3>Luciferase expression assay in vivo</h3><p id="p-28">All mouse studies were approved by the Institutional Animal Care and Use Committee at The Ohio State University and complied with local, state, and federal regulations. mRNA encoding Firefly luciferase was formulated at the concentration of 0.03 mg/mL using TT3 nanoparticlesand dialyzed in 1×PBS. Three mice per group were injected intramuscularly 15 µg mRNA per leg (n=6 legs). Six hours after injection, mice were imaged using a Xenogen IVIS Spectrum In Vivo imaging system (Caliper)</p></div><div id="sec-22" class="subsection"><h3>SARS-CoV-2 antigens expression in vivo</h3><p id="p-29">The mRNAs encoding SARS-CoV-2 antigens, RBD and S, were formulated by TT3 nanoparticles to 0.03 mg/mL and 0.06 mg/mL, respectively. The formulated nanoparticles were dialyzed in 1×PBS. The formulation was injected intramuscularly 15µg RBD-encoding mRNA or 30µg S-encoding mRNA. Mice were euthanized six hours after injection. The muscle tissue at the injection sites was harvested and incubated in 4% paraformaldehyde overnight, followed by 30% sucrose incubation overnight. The tissue was sectioned using Cryotome E Cryostat (Thermo-Shandon) and fixed using acetone. The subsequent staining procedure was the same as that for staining 293T cells. Images were taken on a Nikon A1R Live Cell Confocal microscope with NIS-Elements BR imaging software (version 4.20).</p></div><div id="sec-23" class="subsection"><h3>Data analysis</h3><p id="p-30">All data analysis was conducted in Prism 7 (GraphPad). All t-tests were two-tailed and *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ****P &lt; 0.0001 was considered statistically significant. The p values and specific statistical methods were shown in the figure legends.</p></div></div><div class="section" id="sec-25"><h2 class="">Author contributions</h2><p id="p-32">C.Zeng conceived, designed and performed the experiments, analyzed data, and wrote the paper. X.H. performed ELISA and animal experiments. J.Y. and W.L. contributed to tissue imaging. S.D., C. Zhang, and W.Z. contributed to animal experiments. J.Y contributed to plasmid construction. Y.D. conceived and supervised the project and wrote the paper. The final manuscript was approved by all authors.</p></div><div class="section" id="sec-26"><h2 class="">Competing interests</h2><p id="p-33">The authors declare no competing interests.</p><p id="p-34">Correspondence and requests for materials should be addressed to Y.D.</p></div><div class="section ack" id="ack-1"><h2 class="">Acknowledgements</h2><p id="p-31">We acknowledge the OSU Campus Microscopy &amp; Imaging Facility for providing the instruments and services. Y.D. acknowledges the support from the National Institutes of Health (NIH) through the Maximizing Investigators’ Research Award R35GM119679 of the National Institute of General Medical Sciences as well as the start-up fund from the College of Pharmacy at Ohio State University.</p></div><div class="section ref-list" id="ref-list-1"><h2 class="">References</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a><div class="cit ref-cit ref-web" id="cit-2020.04.01.019877v1.1"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">World Health Organization</span>. <span class="cit-source">Coronavirus disease (COVID-19) outbreak situation</span>. <a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</a> <span class="cit-month">March</span> 29, <span class="cit-pub-date">2020</span></cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.2"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lu</span>,  <span class="cit-name-given-names">R.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</span>. <abbr class="cit-jnl-abbrev">The Lancet</abbr> <span class="cit-vol">395</span>, <span class="cit-fpage">565</span>–<span class="cit-lpage">574</span> (<span class="cit-pub-date">2020</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%26rft.volume%253D395%26rft.spage%253D565%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a><div class="cit ref-cit ref-web" id="cit-2020.04.01.019877v1.3"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">Centers for Disease Control and Prevention</span>. <span class="cit-source">Information for Clinicians on Therapeutic Options for COVID-19 Patients</span>. <a href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html</a> <span class="cit-month">March</span> 29, <span class="cit-pub-date">2020</span></cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.4"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Mascola</span>,  <span class="cit-name-given-names">J.R.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Fauci</span>,  <span class="cit-name-given-names">A.S.</span></span> <span class="cit-article-title">Novel vaccine technologies for the 21st century</span>. <abbr class="cit-jnl-abbrev">Nature Reviews Immunology</abbr> <span class="cit-vol">20</span>, <span class="cit-fpage">87</span>–<span class="cit-lpage">88</span> (<span class="cit-pub-date">2020</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2BReviews%2BImmunology%26rft.volume%253D20%26rft.spage%253D87%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a><div class="cit ref-cit ref-web" id="cit-2020.04.01.019877v1.5"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">World Health Organization</span>. <span class="cit-source">DRAFT landscape of COVID-19 candidate vaccines - 20 March</span> <span class="cit-pub-date">2020</span>. <a href="https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1">https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1</a> <span class="cit-month">March 29</span>, 2020</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.6"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Maruggi</span>,  <span class="cit-name-given-names">G.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhang</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ulmer</span>,  <span class="cit-name-given-names">J.B.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Yu</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-article-title">mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases</span>. <abbr class="cit-jnl-abbrev">Molecular therapy : the journal of the American Society of Gene Therapy</abbr> <span class="cit-vol">27</span>, <span class="cit-fpage">757</span>–<span class="cit-lpage">772</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMolecular%2Btherapy%2B%253A%2Bthe%2Bjournal%2Bof%2Bthe%2BAmerican%2BSociety%2Bof%2BGene%2BTherapy%26rft.volume%253D27%26rft.spage%253D757%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.7" data-doi="10.1038/nrd.2017.243"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Pardi</span>,  <span class="cit-name-given-names">N.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hogan</span>,  <span class="cit-name-given-names">M.J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Porter</span>,  <span class="cit-name-given-names">F.W.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Weissman</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-article-title">mRNA vaccines - a new era in vaccinology</span>. <abbr class="cit-jnl-abbrev">Nature reviews. Drug discovery</abbr> <span class="cit-vol">17</span>, <span class="cit-fpage">261</span>–<span class="cit-lpage">279</span> (<span class="cit-pub-date">2018</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Breviews.%2BDrug%2Bdiscovery%26rft.volume%253D17%26rft.spage%253D261%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnrd.2017.243%26rft_id%253Dinfo%253Apmid%252F29326426%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nrd.2017.243&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=29326426&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.8" data-doi="10.1042/BC20080104"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chatterjee</span>,  <span class="cit-name-given-names">S.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Pal</span>,  <span class="cit-name-given-names">J.K.</span></span> <span class="cit-article-title">Role of 5′- and 3′-untranslated regions of mRNAs in human diseases</span>. <abbr class="cit-jnl-abbrev">Biology of the Cell</abbr> <span class="cit-vol">101</span>, <span class="cit-fpage">251</span>–<span class="cit-lpage">262</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBiology%2Bof%2Bthe%2Bcell%2B%252F%2Bunder%2Bthe%2Bauspices%2Bof%2Bthe%2BEuropean%2BCell%2BBiology%2BOrganization%26rft.stitle%253DBiol%2BCell%26rft.aulast%253DChatterjee%26rft.auinit1%253DS.%26rft.volume%253D101%26rft.issue%253D5%26rft.spage%253D251%26rft.epage%253D262%26rft.atitle%253DRole%2Bof%2B5%2527-%2Band%2B3%2527-untranslated%2Bregions%2Bof%2BmRNAs%2Bin%2Bhuman%2Bdiseases.%26rft_id%253Dinfo%253Adoi%252F10.1042%252FBC20080104%26rft_id%253Dinfo%253Apmid%252F19275763%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1042/BC20080104&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19275763&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000266069500001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.9"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jackson</span>,  <span class="cit-name-given-names">N.A.C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kester</span>,  <span class="cit-name-given-names">K.E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Casimiro</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gurunathan</span>,  <span class="cit-name-given-names">S.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">DeRosa</span>,  <span class="cit-name-given-names">F.</span></span> <span class="cit-article-title">The promise of mRNA vaccines: a biotech and industrial perspective</span>. <abbr class="cit-jnl-abbrev">npj Vaccines</abbr> <span class="cit-vol">5</span>, <span class="cit-fpage">11</span> (<span class="cit-pub-date">2020</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253Dnpj%2BVaccines%26rft.volume%253D5%26rft.spage%253D11%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">↵</a><div class="cit ref-cit ref-book" id="cit-2020.04.01.019877v1.10" data-doi="10.1126/science.aad9868"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hinnebusch</span>,  <span class="cit-name-given-names">A.G.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ivanov</span>,  <span class="cit-name-given-names">I.P.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Sonenberg</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-chapter-title">Translational control by 5’-untranslated regions of eukaryotic mRNAs</span>. <span class="cit-source">Science</span> (<span class="cit-publ-loc">New York, N.Y.</span>) <span class="cit-vol">352</span>, <span class="cit-fpage">1413</span>–<span class="cit-lpage">1416</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.aulast%253DHinnebusch%26rft.auinit1%253DA.%2BG.%26rft.volume%253D352%26rft.issue%253D6292%26rft.spage%253D1413%26rft.epage%253D1416%26rft.atitle%253DTranslational%2Bcontrol%2Bby%2B5%2527-untranslated%2Bregions%2Bof%2Beukaryotic%2BmRNAs%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.aad9868%26rft_id%253Dinfo%253Apmid%252F27313038%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEzOiIzNTIvNjI5Mi8xNDEzIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDQvMDUvMjAyMC4wNC4wMS4wMTk4NzcuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.11"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Mayr</span>,  <span class="cit-name-given-names">C.</span></span> <abbr class="cit-jnl-abbrev">Regulation by 3′-Untranslated Regions. Annual Review of Genetics</abbr> <span class="cit-vol">51</span>, <span class="cit-fpage">171</span>–<span class="cit-lpage">194</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DRegulation%2Bby%2B3%253F-Untranslated%2BRegions.%2BAnnual%2BReview%2Bof%2BGenetics%26rft.volume%253D51%26rft.spage%253D171%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.12"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ferizi</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts</span>. <abbr class="cit-jnl-abbrev">Scientific reports</abbr> <span class="cit-vol">6</span>, <span class="cit-fpage">39149</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScientific%2Breports%26rft.volume%253D6%26rft.spage%253D39149%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.13" data-doi="10.1261/rna.2309906"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Babendure</span>,  <span class="cit-name-given-names">J.R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Babendure</span>,  <span class="cit-name-given-names">J.L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ding</span>,  <span class="cit-name-given-names">J.-H.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Tsien</span>,  <span class="cit-name-given-names">R.Y.</span></span> <span class="cit-article-title">Control of mammalian translation by mRNA structure near caps</span>. <abbr class="cit-jnl-abbrev">RNA</abbr> <span class="cit-vol">12</span>, <span class="cit-fpage">851</span>–<span class="cit-lpage">861</span> (<span class="cit-pub-date">2006</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DRNA%26rft_id%253Dinfo%253Adoi%252F10.1261%252Frna.2309906%26rft_id%253Dinfo%253Apmid%252F16540693%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoicm5hIjtzOjU6InJlc2lkIjtzOjg6IjEyLzUvODUxIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDQvMDUvMjAyMC4wNC4wMS4wMTk4NzcuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.14"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Trepotec</span>,  <span class="cit-name-given-names">Z.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5’-UTRs</span>. <abbr class="cit-jnl-abbrev">Tissue engineering. Part A</abbr> <span class="cit-vol">25</span>, <span class="cit-fpage">69</span>–<span class="cit-lpage">79</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DTissue%2Bengineering.%2BPart%2BA%26rft.volume%253D25%26rft.spage%253D69%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.15"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sample</span>,  <span class="cit-name-given-names">P.J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Human 5′ UTR design and variant effect prediction from a massively parallel translation assay</span>. <abbr class="cit-jnl-abbrev">Nature Biotechnology</abbr> <span class="cit-vol">37</span>, <span class="cit-fpage">803</span>–<span class="cit-lpage">809</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2BBiotechnology%26rft.volume%253D37%26rft.spage%253D803%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.16" data-doi="10.1172/JCI92030"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lee</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors</span>. <abbr class="cit-jnl-abbrev">The Journal of clinical investigation</abbr> <span class="cit-vol">127</span>, <span class="cit-fpage">2433</span>–<span class="cit-lpage">2437</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BJournal%2Bof%2Bclinical%2Binvestigation%26rft.volume%253D127%26rft.spage%253D2433%26rft_id%253Dinfo%253Adoi%252F10.1172%252FJCI92030%26rft_id%253Dinfo%253Apmid%252F28481220%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1172/JCI92030&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=28481220&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.17" data-doi="10.1016/j.cell.2017.02.017"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Richner</span>,  <span class="cit-name-given-names">J.M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Modified mRNA Vaccines Protect against Zika Virus Infection</span>. <abbr class="cit-jnl-abbrev">Cell</abbr> <span class="cit-vol">168</span>, <span class="cit-fpage">1114</span>-<span class="cit-lpage">1125</span>.e1110 (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%26rft.volume%253D168%26rft.spage%253D1114%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cell.2017.02.017%26rft_id%253Dinfo%253Apmid%252F28222903%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.cell.2017.02.017&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=28222903&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.18"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schrom</span>,  <span class="cit-name-given-names">E.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA</span>. <abbr class="cit-jnl-abbrev">Molecular therapy. Nucleic acids</abbr> <span class="cit-vol">7</span>, <span class="cit-fpage">350</span>–<span class="cit-lpage">365</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMolecular%2Btherapy.%2BNucleic%2Bacids%26rft.volume%253D7%26rft.spage%253D350%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.19" data-doi="10.1038/nature10098"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schwanhäusser</span>,  <span class="cit-name-given-names">B.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Global quantification of mammalian gene expression control</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">473</span>, <span class="cit-fpage">337</span>–<span class="cit-lpage">342</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.stitle%253DNature%26rft.aulast%253DSchwanhausser%26rft.auinit1%253DB.%26rft.volume%253D473%26rft.issue%253D7347%26rft.spage%253D337%26rft.epage%253D342%26rft.atitle%253DGlobal%2Bquantification%2Bof%2Bmammalian%2Bgene%2Bexpression%2Bcontrol.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature10098%26rft_id%253Dinfo%253Apmid%252F21593866%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature10098&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21593866&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000290722400040&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.20" data-doi="10.1101/gr.214202"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yoshihama</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The human ribosomal protein genes: sequencing and comparative analysis of 73 genes</span>. <abbr class="cit-jnl-abbrev">Genome research</abbr> <span class="cit-vol">12</span>, <span class="cit-fpage">379</span>–<span class="cit-lpage">390</span> (<span class="cit-pub-date">2002</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DGenome%2BResearch%26rft.stitle%253DGenome%2BRes%26rft.aulast%253DYoshihama%26rft.auinit1%253DM.%26rft.volume%253D12%26rft.issue%253D3%26rft.spage%253D379%26rft.epage%253D390%26rft.atitle%253DThe%2BHuman%2BRibosomal%2BProtein%2BGenes%253A%2BSequencing%2Band%2BComparative%2BAnalysis%2Bof%2B73%2BGenes%26rft_id%253Dinfo%253Adoi%252F10.1101%252Fgr.214202%26rft_id%253Dinfo%253Apmid%252F11875025%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NjoiZ2Vub21lIjtzOjU6InJlc2lkIjtzOjg6IjEyLzMvMzc5IjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDQvMDUvMjAyMC4wNC4wMS4wMTk4NzcuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.21" data-doi="10.1093/nar/gkn248"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yamashita</span>,  <span class="cit-name-given-names">R.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristics</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">36</span>, <span class="cit-fpage">3707</span>–<span class="cit-lpage">3715</span> (<span class="cit-pub-date">2008</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgkn248%26rft_id%253Dinfo%253Apmid%252F18480124%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gkn248&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=18480124&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000257188700018&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.22"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Geyer</span>,  <span class="cit-name-given-names">P.E.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Plasma Proteome Profiling to Assess Human Health and Disease</span>. <abbr class="cit-jnl-abbrev">Cell systems</abbr> <span class="cit-vol">2</span>, <span class="cit-fpage">185</span>–<span class="cit-lpage">195</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2Bsystems%26rft.volume%253D2%26rft.spage%253D185%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text" id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.23" data-doi="10.1093/nar/gkt543"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bai</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhou</span>,  <span class="cit-name-given-names">K.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Doudna</span>,  <span class="cit-name-given-names">J.A.</span></span> <span class="cit-article-title">Hepatitis C virus 3’UTR regulates viral translation through direct interactions with the host translation machinery</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">41</span>, <span class="cit-fpage">7861</span>–<span class="cit-lpage">7874</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgkt543%26rft_id%253Dinfo%253Apmid%252F23783572%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gkt543&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23783572&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000325173300032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.24" data-doi="10.1038/nature19946"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Huang</span>,  <span class="cit-name-given-names">P.-S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Boyken</span>,  <span class="cit-name-given-names">S.E.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Baker</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-article-title">The coming of age of de novo protein design</span>. <abbr class="cit-jnl-abbrev">Nature</abbr> <span class="cit-vol">537</span>, <span class="cit-fpage">320</span>–<span class="cit-lpage">327</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D537%26rft.spage%253D320%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature19946%26rft_id%253Dinfo%253Apmid%252F27629638%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nature19946&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=27629638&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.25" data-doi="10.1016/0022-2836(87)90418-9"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kozak</span>,  <span class="cit-name-given-names">M.</span></span> <span class="cit-article-title">At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells</span>. <abbr class="cit-jnl-abbrev">Journal of molecular biology</abbr> <span class="cit-vol">196</span>, <span class="cit-fpage">947</span>–<span class="cit-lpage">950</span> (<span class="cit-pub-date">1987</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmolecular%2Bbiology%26rft.stitle%253DJ%2BMol%2BBiol%26rft.aulast%253DKozak%26rft.auinit1%253DM.%26rft.volume%253D196%26rft.issue%253D4%26rft.spage%253D947%26rft.epage%253D950%26rft.atitle%253DAt%2Bleast%2Bsix%2Bnucleotides%2Bpreceding%2Bthe%2BAUG%2Binitiator%2Bcodon%2Benhance%2Btranslation%2Bin%2Bmammalian%2Bcells.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0022-2836%252887%252990418-9%26rft_id%253Dinfo%253Apmid%252F3681984%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/0022-2836(87)90418-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=3681984&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1987J839100018&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text" id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.26" data-doi="10.1016/j.tibs.2017.03.004"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hinnebusch</span>,  <span class="cit-name-given-names">A.G.</span></span> <span class="cit-article-title">Structural Insights into the Mechanism of Scanning and Start Codon Recognition in Eukaryotic Translation Initiation</span>. <abbr class="cit-jnl-abbrev">Trends in biochemical sciences</abbr> <span class="cit-vol">42</span>, <span class="cit-fpage">589</span>–<span class="cit-lpage">611</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DTrends%2Bin%2Bbiochemical%2Bsciences%26rft.volume%253D42%26rft.spage%253D589%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.tibs.2017.03.004%26rft_id%253Dinfo%253Apmid%252F28442192%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.tibs.2017.03.004&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=28442192&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.27"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chen</span>,  <span class="cit-name-given-names">S.J.</span></span> <span class="cit-article-title">RNA folding: Conformational statistics, folding kinetics, and ion electrostatics</span>. <abbr class="cit-jnl-abbrev">Annual Review of Biophysics</abbr> <span class="cit-vol">37</span>, <span class="cit-fpage">197</span>–<span class="cit-lpage">214</span> (<span class="cit-pub-date">2008</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnnual%2BReview%2Bof%2BBiophysics%26rft.volume%253D37%26rft.spage%253D197%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text" id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.28" data-doi="10.1038/nrg1379"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">He</span>,  <span class="cit-name-given-names">L.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Hannon</span>,  <span class="cit-name-given-names">G.J.</span></span> <span class="cit-article-title">MicroRNAs: small RNAs with a big role in gene regulation</span>. <abbr class="cit-jnl-abbrev">Nature Reviews Genetics</abbr> <span class="cit-vol">5</span>, <span class="cit-fpage">522</span>–<span class="cit-lpage">531</span> (<span class="cit-pub-date">2004</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Breviews.%2BGenetics%26rft.stitle%253DNat%2BRev%2BGenet%26rft.aulast%253DHe%26rft.auinit1%253DL.%26rft.volume%253D5%26rft.issue%253D7%26rft.spage%253D522%26rft.epage%253D531%26rft.atitle%253DMicroRNAs%253A%2Bsmall%2BRNAs%2Bwith%2Ba%2Bbig%2Brole%2Bin%2Bgene%2Bregulation.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnrg1379%26rft_id%253Dinfo%253Apmid%252F15211354%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nrg1379&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=15211354&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.29" data-doi="10.1093/nar/gks1076"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ricci</span>,  <span class="cit-name-given-names">E.P.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">miRNA repression of translation in vitro takes place during 43S ribosomal scanning</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">41</span>, <span class="cit-fpage">586</span>–<span class="cit-lpage">598</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgks1076%26rft_id%253Dinfo%253Apmid%252F23161679%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gks1076&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23161679&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000312889900080&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text" id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.30"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hentze</span>,  <span class="cit-name-given-names">M.W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Castello</span>,  <span class="cit-name-given-names">A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Schwarzl</span>,  <span class="cit-name-given-names">T.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Preiss</span>,  <span class="cit-name-given-names">T.</span></span> <span class="cit-article-title">A brave new world of RNA-binding proteins</span>. <abbr class="cit-jnl-abbrev">Nature Reviews Molecular Cell Biology</abbr> <span class="cit-vol">19</span>, <span class="cit-fpage">327</span>–<span class="cit-lpage">341</span> (<span class="cit-pub-date">2018</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2BReviews%2BMolecular%2BCell%2BBiology%26rft.volume%253D19%26rft.spage%253D327%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.31" data-doi="10.1093/nar/gkw118"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yamagishi</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tsusaka</span>,  <span class="cit-name-given-names">T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mitsunaga</span>,  <span class="cit-name-given-names">H.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Maehata</span>,  <span class="cit-name-given-names">T.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Hoshino</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-article-title">The STAR protein QKI-7 recruits PAPD4 to regulate post-transcriptional polyadenylation of target mRNAs</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">44</span>, <span class="cit-fpage">2475</span>–<span class="cit-lpage">2490</span> (<span class="cit-pub-date">2016</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgkw118%26rft_id%253Dinfo%253Apmid%252F26926106%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gkw118&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26926106&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">32.</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32. in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.32"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Galarneau</span>,  <span class="cit-name-given-names">A.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Richard</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-article-title">Target RNA motif and target mRNAs of the Quaking STAR protein</span>. <abbr class="cit-jnl-abbrev">Nature Structural &amp; Molecular Biology</abbr> <span class="cit-vol">12</span>, <span class="cit-fpage">691</span>–<span class="cit-lpage">698</span> (<span class="cit-pub-date">2005</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2BStructural%2B%2526%2BMolecular%2BBiology%26rft.volume%253D12%26rft.spage%253D691%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">33.</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33. in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.33"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zearfoss</span>,  <span class="cit-name-given-names">N.R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Clingman</span>,  <span class="cit-name-given-names">C.C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Farley</span>,  <span class="cit-name-given-names">B.M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">McCoig</span>,  <span class="cit-name-given-names">L.M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Ryder</span>,  <span class="cit-name-given-names">S.P.</span></span> <span class="cit-article-title">Quaking Regulates Hnrnpa1 Expression through Its 3′ UTR in Oligodendrocyte Precursor Cells</span>. <abbr class="cit-jnl-abbrev">PLOS Genetics</abbr> <span class="cit-vol">7</span>, <span class="cit-fpage">e1001269</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLOS%2BGenetics%26rft.volume%253D7%26rft.spage%253D1001269e%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">34.</span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34. in text" id="ref-34">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.34" data-doi="10.1128/MCB.01532-08"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Topisirovic</span>,  <span class="cit-name-given-names">I.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer</span>. <abbr class="cit-jnl-abbrev">Molecular and cellular biology</abbr> <span class="cit-vol">29</span>, <span class="cit-fpage">1152</span>–<span class="cit-lpage">1162</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMolecular%2Band%2Bcellular%2Bbiology%26rft_id%253Dinfo%253Adoi%252F10.1128%252FMCB.01532-08%26rft_id%253Dinfo%253Apmid%252F19114552%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoibWNiIjtzOjU6InJlc2lkIjtzOjk6IjI5LzUvMTE1MiI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzA0LzA1LzIwMjAuMDQuMDEuMDE5ODc3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">35.</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35. in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.35" data-doi="10.1016/j.chom.2010.07.003"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sokoloski</span>,  <span class="cit-name-given-names">K.J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">8</span>, <span class="cit-fpage">196</span>–<span class="cit-lpage">207</span> (<span class="cit-pub-date">2010</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DCell%2BHost%2BMicrobe%26rft.aulast%253DSokoloski%26rft.auinit1%253DK.%2BJ.%26rft.volume%253D8%26rft.issue%253D2%26rft.spage%253D196%26rft.epage%253D207%26rft.atitle%253DSindbis%2Bvirus%2Busurps%2Bthe%2Bcellular%2BHuR%2Bprotein%2Bto%2Bstabilize%2Bits%2Btranscripts%2Band%2Bpromote%2Bproductive%2Binfections%2Bin%2Bmammalian%2Band%2Bmosquito%2Bcells.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2010.07.003%26rft_id%253Dinfo%253Apmid%252F20709296%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2010.07.003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=20709296&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">36.</span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36. in text" id="ref-36">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.36" data-doi="10.1093/nar/gks1282"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Terenin</span>,  <span class="cit-name-given-names">I.M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Andreev</span>,  <span class="cit-name-given-names">D.E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dmitriev</span>,  <span class="cit-name-given-names">S.E.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Shatsky</span>,  <span class="cit-name-given-names">I.N.</span></span> <span class="cit-article-title">A novel mechanism of eukaryotic translation initiation that is neither m7G-cap-, nor IRES-dependent</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">41</span>, <span class="cit-fpage">1807</span>–<span class="cit-lpage">1816</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgks1282%26rft_id%253Dinfo%253Apmid%252F23268449%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gks1282&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23268449&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000316351800042&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">37.</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37. in text" id="ref-37">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.37" data-doi="10.1093/nar/gkr560"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Fernandez</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Structural basis for the biological relevance of the invariant apical stem in IRES-mediated translation</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">39</span>, <span class="cit-fpage">8572</span>–<span class="cit-lpage">8585</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgkr560%26rft_id%253Dinfo%253Apmid%252F21742761%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gkr560&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21742761&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000296341100031&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">38.</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38. in text" id="ref-38">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.38" data-doi="10.3201/1107.050219"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jiang</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">He</span>,  <span class="cit-name-given-names">Y.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Liu</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-article-title">SARS vaccine development</span>. <abbr class="cit-jnl-abbrev">Emerging infectious diseases</abbr> <span class="cit-vol">11</span>, <span class="cit-fpage">1016</span>–<span class="cit-lpage">1020</span> (<span class="cit-pub-date">2005</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEmerging%2Binfectious%2Bdiseases%26rft.stitle%253DEmerg%2BInfect%2BDis%26rft.aulast%253DJiang%26rft.auinit1%253DS.%26rft.volume%253D11%26rft.issue%253D7%26rft.spage%253D1016%26rft.epage%253D1020%26rft.atitle%253DSARS%2Bvaccine%2Bdevelopment.%26rft_id%253Dinfo%253Adoi%252F10.3201%252F1107.050219%26rft_id%253Dinfo%253Apmid%252F16022774%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3201/1107.050219&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=16022774&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000230106600005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">39.</span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39. in text" id="ref-39">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.39" data-doi="10.1086/422040"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Leung</span>,  <span class="cit-name-given-names">D.T.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid</span>. <abbr class="cit-jnl-abbrev">The Journal of infectious diseases</abbr> <span class="cit-vol">190</span>, <span class="cit-fpage">379</span>–<span class="cit-lpage">386</span> (<span class="cit-pub-date">2004</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BJournal%2Bof%2Binfectious%2Bdiseases%26rft_id%253Dinfo%253Adoi%252F10.1086%252F422040%26rft_id%253Dinfo%253Apmid%252F15216476%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/422040&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=15216476&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000222254800024&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">40.</span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40. in text" id="ref-40">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.40" data-doi="10.1128/JCM.43.8.3718-3726.2005"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">He</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhou</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Siddiqui</span>,  <span class="cit-name-given-names">P.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Niu</span>,  <span class="cit-name-given-names">J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Jiang</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-article-title">Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus</span>. <abbr class="cit-jnl-abbrev">Journal of Clinical Microbiology</abbr> <span class="cit-vol">43</span>, <span class="cit-fpage">3718</span> (<span class="cit-pub-date">2005</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BMicrobiology%26rft.stitle%253DJ.%2BClin.%2BMicrobiol.%26rft.aulast%253DHe%26rft.auinit1%253DY.%26rft.volume%253D43%26rft.issue%253D8%26rft.spage%253D3718%26rft.epage%253D3726%26rft.atitle%253DIdentification%2Bof%2BImmunodominant%2BEpitopes%2Bon%2Bthe%2BMembrane%2BProtein%2Bof%2Bthe%2BSevere%2BAcute%2BRespiratory%2BSyndrome-Associated%2BCoronavirus%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJCM.43.8.3718-3726.2005%26rft_id%253Dinfo%253Apmid%252F16081901%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamNtIjtzOjU6InJlc2lkIjtzOjk6IjQzLzgvMzcxOCI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzA0LzA1LzIwMjAuMDQuMDEuMDE5ODc3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">41.</span><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference 41. in text" id="ref-41">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.41"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Schoeman</span>,  <span class="cit-name-given-names">D.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Fielding</span>,  <span class="cit-name-given-names">B.C.</span></span> <span class="cit-article-title">Coronavirus envelope protein: current knowledge</span>. <abbr class="cit-jnl-abbrev">Virology Journal</abbr> <span class="cit-vol">16</span>, <span class="cit-fpage">69</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%2BJournal%26rft.volume%253D16%26rft.spage%253D69%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">42.</span><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference 42. in text" id="ref-42">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.42"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">B.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo</span>. <abbr class="cit-jnl-abbrev">Nano Letters</abbr> <span class="cit-vol">15</span>, <span class="cit-fpage">8099</span>–<span class="cit-lpage">8107</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNano%2BLetters%26rft.volume%253D15%26rft.spage%253D8099%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">43.</span><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference 43. in text" id="ref-43">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.43"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhang</span>,  <span class="cit-name-given-names">L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">W.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-article-title">Effect of vaccine administration modality on immunogenicity and efficacy</span>. <abbr class="cit-jnl-abbrev">Expert Rev Vaccines</abbr> <span class="cit-vol">14</span>, <span class="cit-fpage">1509</span>–<span class="cit-lpage">1523</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DExpert%2BRev%2BVaccines%26rft.volume%253D14%26rft.spage%253D1509%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">44.</span><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference 44. in text" id="ref-44">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.44"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hassett</span>,  <span class="cit-name-given-names">K.J.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines</span>. <abbr class="cit-jnl-abbrev">Molecular Therapy - Nucleic Acids</abbr> <span class="cit-vol">15</span>, <span class="cit-fpage">1</span>–<span class="cit-lpage">11</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMolecular%2BTherapy%2B-%2BNucleic%2BAcids%26rft.volume%253D15%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">45.</span><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference 45. in text" id="ref-45">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.45"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Akinc</span>,  <span class="cit-name-given-names">A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs</span>. <abbr class="cit-jnl-abbrev">Nature Nanotechnology</abbr> <span class="cit-vol">14</span>, <span class="cit-fpage">1084</span>–<span class="cit-lpage">1087</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2BNanotechnology%26rft.volume%253D14%26rft.spage%253D1084%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">46.</span><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46. in text" id="ref-46">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.46"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Klauer</span>,  <span class="cit-name-given-names">A.A.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">van Hoof</span>,  <span class="cit-name-given-names">A.</span></span> <span class="cit-article-title">Degradation of mRNAs that lack a stop codon: a decade of nonstop progress</span>. <abbr class="cit-jnl-abbrev">Wiley Interdiscip Rev RNA</abbr> <span class="cit-vol">3</span>, <span class="cit-fpage">649</span>–<span class="cit-lpage">660</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DWiley%2BInterdiscip%2BRev%2BRNA%26rft.volume%253D3%26rft.spage%253D649%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">47.</span><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference 47. in text" id="ref-47">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.47" data-doi="10.1093/nar/gkx279"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Mann</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wright</span>,  <span class="cit-name-given-names">P.R.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Backofen</span>,  <span class="cit-name-given-names">R.</span></span> <span class="cit-article-title">IntaRNA 2.0: enhanced and customizable prediction of RNA–RNA interactions</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">45</span>, <span class="cit-fpage">W435</span>–<span class="cit-lpage">W439</span> (<span class="cit-pub-date">2017</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft.volume%253D45%26rft.spage%253DW435%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgkx279%26rft_id%253Dinfo%253Apmid%252F28472523%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gkx279&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=28472523&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F04%2F05%2F2020.04.01.019877.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">48.</span><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference 48. in text" id="ref-48">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.48"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chen</span>,  <span class="cit-name-given-names">Y.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">X.</span></span> <span class="cit-article-title">miRDB: an online database for prediction of functional microRNA targets</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-vol">48</span>, <span class="cit-fpage">D127</span>–<span class="cit-lpage">D131</span> (<span class="cit-pub-date">2019</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft.volume%253D48%26rft.spage%253DD127%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">49.</span><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49. in text" id="ref-49">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.04.01.019877v1.49"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">B.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zeng</span>,  <span class="cit-name-given-names">C.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Dong</span>,  <span class="cit-name-given-names">Y.</span></span> <span class="cit-article-title">Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing</span>. <abbr class="cit-jnl-abbrev">Nat Protoc</abbr> <span class="cit-vol">13</span>, <span class="cit-fpage">899</span>–<span class="cit-lpage">914</span> (<span class="cit-pub-date">2018</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNat%2BProtoc%26rft.volume%253D13%26rft.spage%253D899%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://biorxivstage.disqus.com/?url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F2020.04.01.019877v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/2020.04.04.024703v1" title="Neural control of steering in walking Drosophila" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/2020.04.04.025544v1" title="Targeting the Src pathway enhances the efficacy of selective FGFR inhibitors in cancers with FGFR3 alterations" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;April 05, 2020.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/2020.04.01.019877v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><i class="icon-external-link-sign"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-supplementary-fragment" >
  
      
  
  <div class="pane-content">
    <p><a href="/content/10.1101/2020.04.01.019877v1.supplementary-material"><i class="icon-file"></i>Supplementary Material </a></p>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/2020.04.01.019877v1.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about bioRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/2020.04.01.019877v1" class="active" data-icon-position="" data-hide-link-title="0">Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from bioRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the bioRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/1229828" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-_dDfjLZ4F1xyMoln4KP0vctIROWiALXxrnov4IDtbPc" />
<input type="hidden" name="form_id" value="forward_form" />
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="1229828" id="node1229828--2" data-pisa="biorxiv;2020.04.01.019877v1" data-pisa-master="biorxiv;2020.04.01.019877" data-seqnum="1229828" data-apath="/biorxiv/early/2020/04/05/2020.04.01.019877.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Chunxi</span> <span class="nlm-surname">Zeng</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Xucheng</span> <span class="nlm-surname">Hou</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Jingyue</span> <span class="nlm-surname">Yan</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Chengxiang</span> <span class="nlm-surname">Zhang</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Wenqing</span> <span class="nlm-surname">Li</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Weiyu</span> <span class="nlm-surname">Zhao</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Shi</span> <span class="nlm-surname">Du</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Yizhou</span> <span class="nlm-surname">Dong</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2020.04.01.019877; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2020.04.01.019877 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;title=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;title=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;text=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;title=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;t=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;title=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;title=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="1229828" id="node1229828--3" data-pisa="biorxiv;2020.04.01.019877v1" data-pisa-master="biorxiv;2020.04.01.019877" data-seqnum="1229828" data-apath="/biorxiv/early/2020/04/05/2020.04.01.019877.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Chunxi</span> <span class="nlm-surname">Zeng</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Xucheng</span> <span class="nlm-surname">Hou</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Jingyue</span> <span class="nlm-surname">Yan</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Chengxiang</span> <span class="nlm-surname">Zhang</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Wenqing</span> <span class="nlm-surname">Li</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Weiyu</span> <span class="nlm-surname">Zhao</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Shi</span> <span class="nlm-surname">Du</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Yizhou</span> <span class="nlm-surname">Dong</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2020.04.01.019877; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2020.04.01.019877 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo&amp;rft.volume&amp;rft.issue&amp;rft.date=2020-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=bioRxiv&amp;rft.au=Zeng%2C+Chunxi&amp;rft.au=Hou%2C+Xucheng&amp;rft.au=Yan%2C+Jingyue&amp;rft.au=Zhang%2C+Chengxiang&amp;rft.au=Li%2C+Wenqing&amp;rft.au=Zhao%2C+Weiyu&amp;rft.au=Du%2C+Shi&amp;rft.au=Dong%2C+Yizhou"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/1229828/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/1229828/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/1229828/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/1229828/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/1229828/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/1229828/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/1229828/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/1229828/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/1229828/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/1229828/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/1229828/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/1229828/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;count=horizontal&amp;via=&amp;text=Leveraging%20mRNAs%20sequences%20to%20express%20SARS-CoV-2%20antigens%20in%20vivo&amp;counturl=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.biorxiv.org/content/10.1101/2020.04.01.019877v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/bioengineering" class="highlight" data-icon-position="" data-hide-link-title="0">Bioengineering<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/animal-behavior-and-cognition" class="" data-icon-position="" data-hide-link-title="0">Animal Behavior and Cognition</a> <span class = "article-count">(1789)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biochemistry" class="" data-icon-position="" data-hide-link-title="0">Biochemistry</a> <span class = "article-count">(3141)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioengineering" class="" data-icon-position="" data-hide-link-title="0">Bioengineering</a> <span class = "article-count">(2136)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioinformatics" class="" data-icon-position="" data-hide-link-title="0">Bioinformatics</a> <span class = "article-count">(11098)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biophysics" class="" data-icon-position="" data-hide-link-title="0">Biophysics</a> <span class = "article-count">(4575)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cancer-biology" class="" data-icon-position="" data-hide-link-title="0">Cancer Biology</a> <span class = "article-count">(3584)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cell-biology" class="" data-icon-position="" data-hide-link-title="0">Cell Biology</a> <span class = "article-count">(5072)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/clinical-trials" class="" data-icon-position="" data-hide-link-title="0">Clinical Trials</a> <span class = "article-count">(137)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/developmental-biology" class="" data-icon-position="" data-hide-link-title="0">Developmental Biology</a> <span class = "article-count">(3114)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ecology" class="" data-icon-position="" data-hide-link-title="0">Ecology</a> <span class = "article-count">(4915)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(2044)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/evolutionary-biology" class="" data-icon-position="" data-hide-link-title="0">Evolutionary Biology</a> <span class = "article-count">(7708)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetics" class="" data-icon-position="" data-hide-link-title="0">Genetics</a> <span class = "article-count">(5844)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genomics" class="" data-icon-position="" data-hide-link-title="0">Genomics</a> <span class = "article-count">(7321)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/immunology" class="" data-icon-position="" data-hide-link-title="0">Immunology</a> <span class = "article-count">(2735)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/microbiology" class="" data-icon-position="" data-hide-link-title="0">Microbiology</a> <span class = "article-count">(8398)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/molecular-biology" class="" data-icon-position="" data-hide-link-title="0">Molecular Biology</a> <span class = "article-count">(3345)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neuroscience" class="" data-icon-position="" data-hide-link-title="0">Neuroscience</a> <span class = "article-count">(20276)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/paleontology" class="" data-icon-position="" data-hide-link-title="0">Paleontology</a> <span class = "article-count">(147)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(529)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-toxicology" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Toxicology</a> <span class = "article-count">(867)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/physiology" class="" data-icon-position="" data-hide-link-title="0">Physiology</a> <span class = "article-count">(1311)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/plant-biology" class="" data-icon-position="" data-hide-link-title="0">Plant Biology</a> <span class = "article-count">(3026)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/scientific-communication-and-education" class="" data-icon-position="" data-hide-link-title="0">Scientific Communication and Education</a> <span class = "article-count">(736)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/synthetic-biology" class="" data-icon-position="" data-hide-link-title="0">Synthetic Biology</a> <span class = "article-count">(976)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/systems-biology" class="" data-icon-position="" data-hide-link-title="0">Systems Biology</a> <span class = "article-count">(3039)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/zoology" class="" data-icon-position="" data-hide-link-title="0">Zoology</a> <span class = "article-count">(503)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js" defer="defer"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__llgGUcz2-k3Jmyyyog-_4yI1wJfGWwx0eQ2lbnM9IIo__t6UjIjIKIAD6nKc6BAU9qmlVV2VR4CBTNQbxlbJPgN0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" src="//d33xdlntwy0kbs.cloudfront.net/cshl_custom.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
  </body>
</html>
